PATH: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization: PATH (EIN 91-1157127)
Tax period: 2015-01-01 to 2015-12-31
Filed: 2016-11-11
IRS object ID: 201623169349303502
Schema version: 2015v2.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2016-11-11T13:31:48-06:00	ReturnTs
Tax Period End	2015-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	521392008	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	GELMAN ROSENBERG & FREEDMAN	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	4550 MONTGOMERY AVE SUITE 650N	AddressLine1Txt
City	BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	208142930	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2015-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	911157127	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	PATH	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	PATH	BusinessNameControlTxt
Phone	2062853500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2201 WESTLAKE AVENUE NO 200	AddressLine1Txt
City	SEATTLE	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98121	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	OLIVIA D POLIUS	PersonNm
Person Title	CHIEF FINANCIAL OFFICER	PersonTitleTxt
Phone	2062853500	PhoneNum
Signature	2016-11-11	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Phone	3019519090	PhoneNum

Field	Value	IRS element (for citing)
Tax	2015	TaxYr
Build TS	2017-02-10 21:41:12Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	STEPHEN B DAVIS	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2201 WESTLAKE AVENUE NO 200	AddressLine1Txt
City	SEATTLE	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98121	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$281,425,424	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.PATH.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1981	FormationYr
Legal Domicile State	WA	LegalDomicileStateCd
Activity Or Mission	SEE PART III, LINE 1.	ActivityOrMissionDesc
Voting Members Governing Body	12	VotingMembersGoverningBodyCnt
Voting Members Independent	12	VotingMembersIndependentCnt
Total Employee	757	TotalEmployeeCnt
Total Volunteers	0	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$286,891,535	PYContributionsGrantsAmt
CY Contributions Grants	$243,499,792	CYContributionsGrantsAmt
PY Program Service Revenue	$22,378	PYProgramServiceRevenueAmt
CY Program Service Revenue	$24,796	CYProgramServiceRevenueAmt
PY Investment Income	$1,565,398	PYInvestmentIncomeAmt
CY Investment Income	$1,908,636	CYInvestmentIncomeAmt
PY Other Revenue	$801,633	PYOtherRevenueAmt
CY Other Revenue	$2,513,804	CYOtherRevenueAmt
PY Total Revenue	$289,280,944	PYTotalRevenueAmt
CY Total Revenue	$247,947,028	CYTotalRevenueAmt
PY Grants And Similar Paid	$71,872,357	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$61,297,455	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$110,831,078	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$110,366,669	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$3,575,067	CYTotalFundraisingExpenseAmt
PY Other Expenses	$93,920,413	PYOtherExpensesAmt
CY Other Expenses	$91,916,808	CYOtherExpensesAmt
PY Total Expenses	$276,623,848	PYTotalExpensesAmt
CY Total Expenses	$263,580,932	CYTotalExpensesAmt
PY Revenues Less Expenses	$12,657,096	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	-$15,633,904	CYRevenuesLessExpensesAmt
Total Assets BOY	$495,616,246	TotalAssetsBOYAmt
Total Assets EOY	$458,736,625	TotalAssetsEOYAmt
Total Liabilities BOY	$54,206,418	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$47,244,164	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$441,409,828	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$411,492,461	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	PATH'S MISSION IS TO IMPROVE THE HEALTH OF PEOPLE AROUND THE WORLD BY ADVANCING TECHNOLOGIES, STRENGTHENING SYSTEMS, AND ENCOURAGING HEALTHY BEHAVIORS. (CONTINUED ON SCHEDULE O)	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$93,828,364	ExpenseAmt
Grant	$26,027,397	GrantAmt
Revenue	$3,740	RevenueAmt
Desc	PRODUCT DEVELOPMENT: PATH IS A GLOBAL LEADER IN IDENTIFYING, DEVELOPING, AND INTRODUCING AFFORDABLE, EFFECTIVE, AND EASY-TO-USE HEALTH TECHNOLOGIES TO ADDRESS URGENT AND ENTRENCHED HEALTH CHALLENGES. OUR VACCINES, DRUGS, DIAGNOSTICS, AND DEVICES ARE EMPOWERING PEOPLE WORLDWIDE.PATH WORKS WITH GOVERNMENTS, NONGOVERNMENTAL ORGANIZATIONS, PRIVATE COMPANIES, EDUCATIONAL INSTITUTIONS, AND OTHER GROUPS TO SHEPHERD HEALTH TECHNOLOGIES AND OTHER INNOVATIONS ALL THE WAY FROM BRIGHT IDEA TO LARGE-SCALE USE. WE OVERCOME BARRIERS ON THIS "JOURNEY OF INNOVATION," INCLUDING MARKET FAILURES, GAPS IN DEMAND AND SUPPLY, POLICY AND REGULATORY ROADBLOCKS, AND OTHER CONSIDERATIONS TO ENSURE THAT SMART SOLUTIONS REACH THE PEOPLE WHO NEED THEM. WE SPECIALIZE IN THE MIDDLE STEPS-SUCH AS TESTING AND REFINING INNOVATIONS, GAINING REGULATORY APPROVAL, FOSTERING A SUPPORTIVE POLICY ENVIRONMENT, BRINGING PRODUCTS SUCCESSFULLY TO MARKET, CREATING SUSTAINABLE MARKETS IN LOW-RESOURCE SETTINGS, AND INTRODUCING NEW APPROACHES. ONE AREA OF FOCUS FOR PATH IS ACCELERATING THE DEVELOPMENT AND DELIVERY OF VACCINES THAT PROVIDE PROTECTION AGAINST DISEASES THAT ARE COMMON IN LOW- AND MIDDLE-INCOME COUNTRIES. FOR EXAMPLE, IN 2015, WE CONTINUED TO SUPPORT THE INTRODUCTION OF A VACCINE AGAINST JAPANESE ENCEPHALITIS, AN INCURABLE DISEASE COMMON IN SOUTHEAST ASIA AND THE WESTERN PACIFIC. IN COLLABORATION WITH A CHINESE VACCINE MANUFACTURER, WE WORKED WITH COUNTRY GOVERNMENTS IN CAMBODIA AND NEPAL TO LAY THE GROUNDWORK FOR THE INTRODUCTION AND EXPANSION OF VACCINATION PROGRAMS. TO DATE, OUR EFFORTS HAVE RESULTED IN DELIVERY OF MORE THAN 232 MILLION DOSES OF VACCINE ACROSS SIX COUNTRIES. WE ALSO WORKED IN 2015 TO EXPAND USE OF MENAFRIVAC, A LOW-COST VACCINE DEVELOPED BY PATH, THE WORLD HEALTH ORGANIZATION, AND SERUM INSTITUTE OF INDIA PVT. LTD. (SIIPL). THIS VACCINE PROTECTS CHILDREN AND YOUNG ADULTS FROM DEBILITATING AND OFTEN DEADLY SEROGROUP A MENINGOCOCCAL MENINGITIS, WHICH HAS BEEN VIRTUALLY ELIMINATED WHEREVER THE VACCINE HAS BEEN INTRODUCED. BY THE END OF 2015, MORE THAN 235 MILLION PEOPLE HAD RECEIVED THE VACCINE IN MASS IMMUNIZATION CAMPAIGNS, AND THE VACCINE WAS POISED FOR INTRODUCTION INTO ROUTINE IMMUNIZATION PROGRAMS. IN PARTNERSHIP WITH SIIPL, PATH ALSO CONTINUED DEVELOPMENT OF A VACCINE TO PROTECT AGAINST OTHER SEROGROUPS OF MENINGOCOCCAL MENINGITIS THAT CAUSE EPIDEMICS IN AFRICA.TO STOP MALARIA, PATH IS ACCELERATING THE DEVELOPMENT OF MORE THAN 20 MALARIA VACCINE CANDIDATES AND APPROACHES. IN 2015, WE PRESENTED THE RESULTS OF A PHASE 3 TRIAL OF PATH AND GLAXOSMITHKLINE'S RTS,S MALARIA VACCINE CANDIDATE TO EUROPEAN REGULATORS, WHO SUBSEQUENTLY ISSUED A POSITIVE OPINION, INFORMING A RECOMMENDATION FROM THE WORLD HEALTH ORGANIZATION FOR PILOT IMPLEMENTATION IN AFRICA. WE ALSO ADVANCED RESEARCH ON WHETHER AN ALTERNATIVE-DOSE FORMULATION OF RTS,S COULD IMPROVE PROTECTION.WE CONTINUED THE FIGHT AGAINST DIARRHEAL DISEASES, THE SECOND-LEADING CAUSE OF DEATH AMONG CHILDREN IN LOW-INCOME COUNTRIES. TO COMBAT ROTAVIRUS, A MAJOR CAUSE OF SEVERE DIARRHEA, WE PARTNERED WITH SIIPL TO STUDY A VACCINE THAT MAY REMAIN STABLE AND POTENT EVEN DURING EXTENDED PERIODS WITHOUT REFRIGERATION, ENABLING WIDER USE IN REMOTE COMMUNITIES. WE COMPLETED ENROLLMENT FOR A PHASE 3 EFFICACY STUDY OF THE VACCINE (THE LARGEST EVER UNDERTAKEN AMONG CHILDREN IN INDIA) AND BEGAN A STUDY TO EXAMINE CLINICAL LOT CONSISTENCY AND POTENTIAL INTERFERENCE WITH OTHER ROUTINE VACCINES. FINALLY, ROTAVAC, AN INDIAN-MADE VACCINE DEVELOPED WITH PATH SUPPORT, REMAINED ON TRACK FOR INTRODUCTION IN INDIA'S PUBLIC SECTOR IN 2016. WE ALSO CONDUCTED CLINICAL TRIALS OF VACCINE CANDIDATES THAT MAY PROVIDE PROTECTION AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) AND SHIGELLA, LEADING CAUSES OF BACTERIAL DIARRHEAL ILLNESS. IN 2015, FOR EXAMPLE, WE BEGAN A CLINICAL STUDY IN BANGLADESH OF ETVAX, A VACCINE CANDIDATE THAT MAY PROTECT AGAINST ETEC. TO HELP STOP SHIGELLA, WE PARTNERED WITH THE WALTER REED ARMY INSTITUTE OF RESEARCH TO STUDY A VACCINE CANDIDATE THAT WE FOUND TO BE SAFE AND CAPABLE OF PRODUCING AN IMMUNE RESPONSE IN CHILDREN.PATH ALSO ADVANCED DEVELOPMENT OF LOW-COST VACCINE CANDIDATES TO PROTECT CHILDREN AGAINST PNEUMOCOCCAL BACTERIA, THE TOP CAUSE OF SEVERE CHILDHOOD PNEUMONIA. IN THE GAMBIA, FOR INSTANCE, WE EVALUATED A PNEUMOCOCCAL CONJUGATE VACCINE (PCV-10) CANDIDATE DESIGNED TO BE AFFORDABLE AND TO PROVIDE PROTECTION AGAINST THE TEN BACTERIAL SEROTYPES CAUSING THE MOST CASES OF INVASIVE PNEUMOCOCCAL DISEASE IN AFRICA AND ASIA. IN KENYA, PATH AND OUR PARTNERS ALSO STUDIED A VACCINE CANDIDATE WITH THE POTENTIAL TO PROVIDE LOW-COST, BROAD PROTECTION ACROSS MANY SEROTYPES. IN ADDITION, WE HELPED THE GOVERNMENTS OF MORE THAN 20 COUNTRIES IN AFRICA AND ASIA PLAN, IMPLEMENT, AND EVALUATE USE OF HUMAN PAPILLOMAVIRUS (HPV) VACCINE TO PROTECT AGAINST CERVICAL CANCER. WE ALSO COLLABORATED WITH GOVERNMENT AND LOCAL GROUPS IN ETHIOPIA TO INCREASE VACCINE DEMAND AND IMMUNIZATION COVERAGE. MUCH OF OUR WORK IN 2015 TO DEVELOP AND ADVANCE TECHNOLOGIES TO IMPROVE THE ADMINISTRATION OF VACCINES AND DRUGS CENTERED ON DETERMINING THE VALUE, APPROPRIATENESS, AND ACCEPTABILITY OF INJECTION TECHNOLOGIES, SUCH AS DISPOSABLE-SYRINGE JET INJECTORS AND MICRONEEDLE PATCHES THAT DELIVER VACCINES OR DRUGS THROUGH THE SKIN. FOR EXAMPLE, WE ADVANCED A FIRST-OF-ITS KIND PATCH TO DELIVER DRUGS THROUGH THE SKIN OR MUCOUS MEMBRANES TO PREVENT HIV INFECTION. OUR TEAMS ALSO INVESTIGATED OPTIONS FOR INTRADERMAL VACCINE DELIVERY BECAUSE SOME VACCINES MAY BE PROTECTIVE AT FAR LOWER DOSES WHEN ADMINISTERED DIRECTLY UNDER THE SKIN. IN ADDITION, WE TESTED FORMULATION TECHNOLOGIES AND APPROACHES THAT CAN MAKE VACCINES EASIER TO TRANSPORT AND MORE HEAT-STABLE, AND WE INVESTIGATED THE USE OF VARIOUS ADJUVANTS, WHICH ARE INGREDIENTS IN A VACCINE THAT CAN INCREASE THE BODY'S IMMUNOLOGICAL RESPONSE. WE ALSO SUPPORTED EFFORTS TO IMPROVE THE SYSTEMS AND EQUIPMENT THAT COUNTRIES USE TO MOVE VACCINES FROM MANUFACTURER TO STORAGE TO CLINIC. THESE ACTIVITIES RANGED FROM CREATING OR TESTING NEW REFRIGERATION EQUIPMENT AND TRANSPORT COOLERS TO EVALUATING SUPPLY SYSTEMS AND TRAINING HEALTH WORKERS.ONE RESULT OF PATH'S DRUG DEVELOPMENT WORK IN 2015 WAS THE SHIPMENT OF 51 MILLION ANTIMALARIAL TREATMENTS MADE WITH SEMISYNTHETIC ARTEMISININ TO MORE THAN 20 COUNTRIES IN SUB-SAHARAN AFRICA. PATH AND OUR PARTNERS PREVIOUSLY DEVELOPED AND SCALED UP USE OF SEMISYNTHETIC ARTEMISININ TO COMPLEMENT BOTANICAL SUPPLIES OF ARTEMISIN, HELPING TO IMPROVE ACCESS TO MALARIA TREATMENT FOR MILLIONS OF PEOPLE. WE ALSO PARTNERED WITH THE CLINTON HEALTH ACCESS INITIATIVE TO ADVANCE STABILIZATION OF ARTEMISININ MARKETS BY DEVELOPING PROJECTIONS FOR FUTURE SUPPLY AND DEMAND FOR THE INGREDIENT. TO REDUCE DIARRHEAL DISEASE, PATH SUPPORTED THE STUDY OF DRUG CANDIDATES TO FIGHT CRYPTOSPORIDIUM, A LEADING CAUSE OF DIARRHEAL DISEASE AND A MAJOR CAUSE OF MALNUTRITION AND OTHER HEALTH ISSUES AMONG YOUNG CHILDREN. ONLY ONE DRUG IS CURRENTLY APPROVED FOR TREATMENT, AND NEW THERAPIES ARE URGENTLY NEEDED.IN WORK TO HELP PREVENT HIV INFECTION, WE COLLABORATED WITH GLOBAL PARTNERS TO CONDUCT A PHASE 2 STUDY OF A LONG-ACTING INJECTABLE FORMULATION OF RILPIVIRINE TO TEST ITS SAFETY AND ACCEPTABILITY FOR PREEXPOSURE PROPHYLAXIS (PREP). A NEW FORMULATION THAT REQUIRES LESS-FREQUENT DOSING MAY IMPROVE UPTAKE AND TREATMENT ADHERENCE AND EXPAND THE GLOBAL TOOLBOX OF PREVENTION INTERVENTIONS AVAILABLE TO DOCTORS AND PATIENTS. WE ALSO ADVANCED LOW-COST, CULTURALLY APPROPRIATE METHODS TO DELIVER ANTIRETROVIRAL DRUGS AND MICROBICIDES. THIS INCLUDED ADVANCING USE OF THE SILCS DIAPHRAM TO BOTH DELIVER MIRCOBICIDE GEL AND PREVENT PREGNANCY; DEVELOPING AND TESTING SELF-ADMINISTERED, FAST-DISSOLVING MICROBICIDE VAGINAL INSERTS FOR THE PREVENTION OF HIV INFECTION; AND EXPLORING USE OF A LOW-COST, ENVIRONMENTALLY SOUND PAPER APPLICATOR FOR MICROBICIDE GEL DELIVERY. PATH ALSO DEVELOPS, ADAPTS, AND INTRODUCES DEVICES AND TOOLS TO IMPROVE NUTRITION; MATERNAL, NEWBORN, AND REPRODUCTIVE HEALTH; AND WATER AND SANITATION IN LOW-RESOURCE SETTINGS. FOR EXAMPLE, PATH WORKED WITH PARTNERS IN 2015 TO BRING A NEW FEEDING CUP TO MARKET THAT WILL HELP CAREGIVERS AND HEALTH WORKERS GIVE LIFESAVING BREASTMILK TO THE 9 MILLION INFANTS IN AFRICA AND ASIA WHO HAVE DIFFICULTY BREASTFEEDING. IN 2015, THE WOMAN'S CONDOM ACHIEVED PREQUALIFICATION BY THE WORLD HEALTH ORGANIZATION AND UNITED NATIONS POPULATION FUND, A CRITICAL STEP TOWARD INCREASING ACCESS WORLDWIDE. A PATH-LED PRODUCT DEVELOPMENT PARTNERSHIP PAVED THE WAY FOR INCREASED MANUFACTURING CAPACITY AND REGULATORY APPROVALS NEEDED TO EXPAND ACCESS TO NEW MARKETS.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$71,613,093	ExpenseAmt
Grant	$17,733,260	GrantAmt
Revenue	$1,056	RevenueAmt
Desc	PUBLIC HEALTH: PATH'S PUBLIC HEALTH PORTFOLIO ENCOMPASSES HIV/AIDS AND TUBERCULOSIS; MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION; REPRODUCTIVE HEALTH; MALARIA CONTROL AND ELIMINATION; AND NONCOMMUNICABLE DISEASES. IT ALSO INCLUDES OUR WORK ON DIGITAL HEALTH SOLUTIONS ACROSS A RANGE OF HEALTH AREAS. IN ALL OUR PUBLIC HEALTH EFFORTS, WE COLLABORATE WITH GOVERNMENTS, COMMUNITIES, AND CIVIL-SOCIETY GROUPS TO STRENGTHEN THE LOCAL AND NATIONAL HEALTH SYSTEMS THAT PROVIDE SERVICES. IN 2015, OUR EFFORTS TO REDUCE THE GLOBAL BURDEN OF HIV/AIDS AND TB INCLUDED DEVELOPING AND EXPANDING THE USE OF LIFESAVING PREVENTION TOOLS, SIMPLER AND AFFORDABLE DIAGNOSTICS, NEW TREATMENT FORMULATIONS, AND INNOVATIVE SERVICE DELIVERY APPROACHES FOR HIV AND CO-INFECTIONS. OUR WORK TO IMPROVE LABORATORY SYSTEMS ADVANCED ACCESSIBLE AND AFFORDABLE DIAGNOSTIC TESTS TO FILL GAPS IN SELF-TESTING, EARLY INFANT DIAGNOSIS AND TREATMENT, VIRAL LOAD DETECTION, AND MONITORING FOR DRUG RESISTANCE. WE FOCUSED ON THE UNIQUE NEEDS OF MARGINALIZED AND HARD-TO-REACH GROUPS, INCLUDING ADOLESCENT GIRLS AND YOUNG WOMEN, ORPHANS AND VULNERABLE CHILDREN, PEOPLE WITH BOTH HIV AND TB, SEX WORKERS AND THEIR CLIENTS, MEN WHO HAVE SEX WITH MEN, AND PEOPLE WHO INJECT DRUGS. PATH ALSO SUPPORTED EFFORTS TO INTEGRATE SCREENING AND TREATMENT FOR NONCOMMUNICABLE DISEASES, SUCH AS DIABETES AND CARDIOVASCULAR DISEASE, INTO HIV TESTING AND SERVICE DELIVERY AND VICE VERSA. PATH HELPED COUNTRIES STRENGTHEN EXISTING HEALTH STRUCTURES TO IMPROVE DIAGNOSIS, TREATMENT, AND CARE FOR HIV AND OTHER HEALTH CONCERNS. IN WESTERN KENYA, FOR EXAMPLE, OUR AIDS, POPULATION, AND HEALTH INTEGRATED ASSISTANCE PROGRAM (APHIAPLUS) INTEGRATED HIV/AIDS, REPRODUCTIVE HEALTH, TB, MALARIA, AND OTHER SERVICES TO HELP MORE PEOPLE ACCESS A GREATER SPECTRUM OF SERVICES. IN THE DEMOCRATIC REPUBLIC OF THE CONGO, PATH LED PROVICPLUS, A WIDE-REACHING HIV/AIDS PROJECT THAT SUPPORTS HEALTH FACILITIES AND HEALTH ZONES TO PROVIDE AN INTEGRATED PACKAGE OF HIV TESTING, TREATMENT, CARE, AND PREVENTION SERVICES. IN 2015, PATH EXPANDED PROVISION OF FAMILY PLANNING SERVICES IN SUPPORTED FACILITIES AND TRAINED FACILITY STAFF TO OFFER CRITICAL MATERNAL, NEWBORN, AND CHILD HEALTH SERVICES. IN VIETNAM, PATH PILOTED NEW APPROACHES TO HELP CONTROL HIV AMONG KEY POPULATIONS. FOR EXAMPLE, WE EQUIPPED LOCAL GROUPS OPERATED BY MEMBERS OF KEY POPULATIONS TO SUPPORT SERVICES AND ENCOURAGE UPTAKE AMONG THEIR PEERS, AND WE HELPED TO DEVELOP A LOCAL COMMERCIAL CONDOM MARKET. IN THE FIGHT AGAINST MALARIA, PATH IS DEVELOPING AND DEPLOYING AN ARRAY OF INNOVATIONS, INCLUDING AN UNPARALLED PORTFOLIO OF MALARIA VACCINE CANDIDATES AND COMMUNITY-LEVEL STRATEGIES TO DETECT, TRACK, AND TREAT EVERY LAST CASE OF TRANSMISSION. IN 2015, WE ESTABLISHED A NEW PATH CENTER FOR MALARIA CONTROL AND ELIMINATION, HARNESSING OUR SCIENTIFIC EXPERTISE, GLOBAL PARTNERSHIPS, AND ON-THE-GROUND EXPERIENCE TO PURSUE OUR GOAL OF A WORLD WITHOUT MALARIA. IN ZAMBIA, IN PARTNERSHIP WITH THE MINISTRY OF HEALTH, WE CONTINUED TO EVALUATE THE EFFECTS OF ADMINISTERING THE ANTIMALARIAL DRUG DIHYDROARTEMISININ-PIPERAQUINE TO ENTIRE POPULATIONS AND TARGETED SUBSETS IN THE COUNTRY'S SOUTHERN PROVINCE. OUR COMPREHENSIVE APPROACH TO ELIMINATING MALARIA-WHICH INCLUDES SURVEILLANCE, TESTING, AND TREATMENT-HAS PROVEN SO SUCCESSFUL THAT ZAMBIA IS MAKING IT A CENTRAL FEATURE OF ITS NATIONWIDE PROGRAM.IN ZAMBIA AND ETHIOPIA, PATH PROVIDED SUPPORT FOR MALARIA INDICATOR SURVEYS TO ASSESS PROGRESS, HIGHLIGHT GAPS, AND INFORM PROGRAM DECISIONS. WE ALSO ACCELERATED THE DEVELOPMENT AND AVAILABILITY OF HIGH-QUALITY DIAGNOSTIC TESTS THAT CAN DETECT LOW LEVELS OF INFECTION AND ASYMPTOMATIC CASES, ENHANCING EFFORTS TO ELIMINATE THE DISEASE.IN ADDITION, UNDER THE PRESIDENT'S MALARIA INITIATIVE, PATH AND OUR PARTNERS WORKED IN MULTIPLE COUNTRIES IN AFRICA AND ASIA TO EXPAND USE OF HIGH-QUALITY DIAGNOSTICS, FOSTER APPROPRIATE TREATMENT OF FEBRILE ILLNESS, AND FACILITATE PARTNERSHIPS WITH PRIVATE-SECTOR ORGANIZATIONS TO IMPROVE MALARIA CARE. TARGET COUNTRIES INCLUDED CAMBODIA, THE DEMOCRATIC REPUBLIC OF THE CONGO, ETHIOPIA, GHANA, KENYA, MALAWI, MALI, NIGERIA, SENEGAL, TANZANIA, AND ZAMBIA.IN OUR EFFORTS TO IMPROVE REPRODUCTIVE HEALTH, PATH WORKS TO INCREASE ACCESS TO A VARIETY OF SAFE AND AFFORDABLE FAMILY PLANNING OPTIONS, IMPROVE SCREENING AND TREATMENT FOR CERVICAL AND BREAST CANCERS, PREVENT SEXUALLY TRANSMITTED INFECTIONS, ADVOCATE FOR HEALTH SERVICES AND SUPPLIES, INTRODUCE NEW CONTRACEPTIVE TECHNOLOGIES, AND ENCOURAGE HEALTHY BEHAVIORS. IN 2015, WE COORDINATED COUNTRY-LED PILOT USE OF A NEW FORM OF INJECTABLE CONTRACEPTION, SAYANA PRESS. THIS PRODUCT COMBINES A LOWER-DOSE FORMULATION OF THE WIDELY USED CONTRACEPTIVE DEPO-PROVERA WITH THE PATH-DEVELOPED UNIJECT INJECTION SYSTEM. NEARLY 275,000 DOSES WERE ADMINISTERED IN 2015 TO WOMEN IN BURKINA FASO, NIGER, SENEGAL, AND UGANDA, INCLUDING 75,000 WOMEN WHO WERE USING MODERN CONTRACEPTION FOR THE FIRST TIME. HUNDREDS OF WOMEN IN SENEGAL AND UGANDA ALSO TOOK PART IN STUDIES ON SELF-INJECTION. EARLY RESULTS INDICATE THAT MOST CAN SUCCESSFULLY ADMINISTER THE CONTRACEPTIVE THEMSELVES, POTENTIALLY INCREASING WOMEN'S CONTROL OF AND ACCESS TO FAMILY PLANNING. SAYANA PRESS SELF-INJECTION WAS APPROVED BY THE UNITED KINGDOM'S REGULATORY AUTHORITY IN 2015, AND SEVERAL EUROPEAN UNION COUNTRIES HAVE ALSO APPROVED SELF-INJECTION.PATH ALSO WORKED WITH PARTNERS WORLDWIDE AND IN SEVERAL COUNTRIES TO IMPROVE THE PREVENTION, DETECTION, AND TREATMENT OF CERVICAL CANCER, WHICH IS MOST OFTEN CAUSED BY INFECTION WITH HUMAN PAPILLOMAVIRUS (HPV). FOR EXAMPLE, WE PARTNERED WITH COMPANIES TO DEVELOP NEW DEVICES TO IMPROVE PRECANCER TREATMENT IN LOW-RESOURCE SETTINGS. IN UGANDA, WE HELPED TO BUILD CAPACITY FOR TRAINING HEALTH CARE PROVIDERS IN RAPID SCREENING AND SAME-DAY TREATMENT OF WOMEN WITH PRECANCEROUS LESIONS. PARTNERING WITH THE MINISTRIES OF HEALTH IN GUATEMALA, NICARAGUA, AND HONDURAS, WE PROVIDED TECHNICAL ASSISTANCE TO INTRODUCE AND QUICKLY SCALE UP HPV TESTING FOR PRIMARY CERVICAL CANCER SCREENING. THIS METHOD ENABLES WOMEN TO COLLECT THEIR OWN SAMPLES FOR SCREENING, REDUCING BOTTLENECKS IN THE HEATLH CARE SYSTEM AND ALLOWING GOVERNMENTS TO FOCUS ON WOMEN WHO ARE AT GREATEST RISK OF DEVELOPING CANCER. PATH ALSO CONTINUED TO SERVE IN 2015 AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION, A GLOBAL PARTNERSHIP OF ABOUT 300 PUBLIC, PRIVATE, AND NONGOVERNMENTAL ORGANIZATIONS WORKING TO EXPAND ACCESS TO SUPPLIES, SERVICES, AND OPTIONS FOR PREVENTING UNINTENDED PREGNANCIES AND SEXUALLY TRANSMITTED INFECTIONS. IN OUR WORK TO ADDRESS THE GROWING BURDEN OF NONCOMMUNICABLE DISEASES-INCLUDING DIABETES, CARDIOVASCULAR DISEASE, AND CANCERS-OUR GOAL IS TO REDUCE ILLNESS AND DEATH BY INCREASING ACCESS TO PREVENTION AND CARE. IN 2015, PATH CONTINUED A RANGE OF PROJECTS, OFTEN IN PARTNERSHIP WITH MINISTRIES OF HEALTH, TO ADDRESS CHALLENGES IN ACCESSING AND PROVIDING NONCOMMUNICABLE DISEASE (NCD) SERVICES IN RESOURCE-CONSTRAINED HEALTH SYSTEMS. THE NO EMPTY SHELVES PROJECT, FOR EXAMPLE, GATHERED EVIDENCE ON BARRIERS AND OPPORTUNITIES AROUND THE AVAILABILITY AND AFFORDABILITY OF KEY NCD SUPPLIES IN LOW-RESOURCE SETTINGS. WE ARE NOW LEVERAGING THE DATA AND FINDINGS TO MOBILIZE STAKEHOLDERS TO IMPROVE ACCESS TO ESSENTIAL NCD MEDICINES AND TECHNOLOGIES, WITH AN INITIAL FOCUS ON DIABETES.TO IMPROVE MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION, PATH WORKS WITH PARTNERS TO DESIGN, IMPLEMENT, AND EVALUATE TECHNOLOGIES AND APPROACHES TO REDUCE ILLNESS AND DEATH AND GIVE CHILDREN THE BEST POSSIBLE START IN LIFE. OUR INTEGRATED, COST-EFFECTIVE SOLUTIONS REACHED MOTHERS AND CHILDREN IN COUNTRIES ACROSS AFRICA, ASIA, EASTERN EUROPE, THE MIDDLE EAST, AND LATIN AMERICA AND THE CARIBBEAN. IN 2015, THROUGH THE NUTRITION EMBEDDING EVALUATION PROGRAM, PATH HELPED 18 GRANTEES EVALUATE THE IMPACT OF NUTRITION PROGRAMS IMPLEMENTED BY NONGOVERNMENTAL ORGANIZATIONS AND LOCAL CIVIL-SOCIETY GROUPS IN COUNTRIES AROUND THE WORLD. THROUGH ROBUST EVALUATIONS, THE PROGRAM ADDED TO THE EVIDENCE BASE ON WHAT WORKS IN IMPROVING MATERNAL AND CHILD NUTRITION OUTCOMES. IN THE MAXIMIZING THE QUALITY OF SCALING UP NUTRITION (MQSUN) PROJECT, PATH HELPED MANY COUNTRIES STRENGTHEN NUTRITION PROGRAMS, PROVIDING TECHNICAL ASSISTANCE THROUGH INTERNATIONAL AND LOCALLY RECRUITED EXPERTS. AN INDEPENDENT EVALUATION OF MQSUN CONCLUDED THAT THE PROGRAM WAS EFFECTIVE AND EFFICIENT.PATH ALSO LED EFFORTS IN SOUTH AFRICA AND ELSEWHERE TO SCALE UP USE OF HUMAN MILK BANKS SO NEWBORNS AND INFANTS BENEFIT FROM BREAST MILK EVEN WHEN THEIR MOTHERS ARE UNABLE TO BREASTFEED. MILK BANKS USE DONATED EXTRA MILK FROM LACTATING MOTHERS, PASTEURIZE IT TO MAKE IT SAFE, AND FREEZE IT UNTIL IT IS NEEDED.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$37,704,208	ExpenseAmt
Grant	$13,847,933	GrantAmt
Revenue	-$37,698	RevenueAmt
Desc	INTERNATIONAL DEVELOPMENT: PATH'S ON-THE-GROUND EXPERIENCE ALLOWS US TO APPLY TAILOR-MADE SOLUTIONS TO URGENT HEALTH NEEDS IN THE COMMUNITIES WE SERVE. WE COLLABORATE WITH COUNTRY PARTNERS TO IMPLEMENT SUSTAINABLE, COUNTRY-OWNED INNOVATIONS THAT STRENGTHEN HEALTH SYSTEMS, ENCOURAGE HEALTHIER BEHAVIORS, AND FOSTER MORE EQUAL ACCESS TO CARE AND SERVICES. IN 2015, OUR INTERNATIONAL DEVELOPMENT PORTFOLIO SUPPORTED WORK IN MORE THAN 70 COUNTRIES, RANGING FROM SMALL-SCALE PILOTS TO LARGE, MULTI-COUNTRY EFFORTS. EACH PROJECT WAS DESIGNED TO COMPLEMENT EXISTING COUNTRY AND COMMUNITY STRENGTHS, PRIORITIES, AND PROGRAMS. TO ILLUSTRATE PATH'S EFFORTS IN INTERNATIONAL DEVELOPMENT, WE PROVIDE HIGHLIGHTS OF OUR WORK IN 2015 IN TANZANIA, KENYA, THE DEMOCRATIC REPUBLIC OF THE CONGO, AND INDIA.IN TANZANIA, PATH WORKED WITH THE MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER, ELDERS, AND CHILDREN (MOHDGEC) AND PARTNERS THROUGHOUT THE COUNTRY TO IMPROVE HEALTH BY ENHANCING DATA QUALITY AND USE, STRENGTHENING HEALTH SYSTEMS, AND ADDRESSING LEADING HEALTH THREATS. OUR WORK TO FIGHT MALARIA INCLUDED ROLLING OUT THE USE OF RAPID DIAGNOSTIC TESTS, WHICH ALLOW HEALTH WORKERS TO DETECT INFECTION AND CUSTOMIZE TREATMENT QUICKLY, CONSISTENTLY, AND SAFELY. WE ALSO PROVIDED TRAINING AND SUPERVISION TO HELP LOCAL PROVIDERS USE NATIONAL GUIDELINES TO IMPROVE MALARIA CASE MANAGEMENT, TREATMENT, AND DIAGNOSIS. OUR WORK COVERED EIGHT REGIONS IN TANZANIA, BUILDING CAPACITY AT HUNDREDS OF FACILITIES AND AMONG HUNDREDS OF HEALTH CARE WORKERS. WE ARE ALSO WORKING TO BUILD SUPPLY CHAINS FOR MALARIA-RELATED PRODUCTS AND SERVICES ACROSS CHALLENGING GEOGRAPHY, DEVELOPING A TABLET-BASED TOOL TO PROVIDE REAL-TIME FEEDBACK ON SUPPLY CHAIN CHALLENGES, IMPROVING IMMUNIZATION DATA CAPTURE AND USE, AND SUPPORTING A GOVERNMENT STUDY ON RESISTANCE TO THE DRUG MOST COMMONLY USED TO TREAT MALARIA. IN 2015, PATH JOINED A GLOBAL EFFORT TO IMPROVE GLOBAL HEALTH SECURITY BY PREPARING FOR EMERGING HEALTH THREATS SUCH AS ZIKA AND EBOLA. IN COLLABORATION WITH THE US CENTERS FOR DISEASE CONTROL AND PREVENTION AND COUNTRY PARTNERS, WE WORKED IN TANZANIA TO STRENGTHEN THE DISEASE SURVEILLANCE SYSTEM SO THAT LEADERS CAN QUICKLY AND EFFECTIVELY DETECT AND RESPOND TO CROSS-BORDER PANDEMIC THREATS AND PUBLIC HEALTH EMERGENCIES. WE ALSO HELPED TANZANIANS FIGHT ONE OF THE WORLD'S HIGHEST BURDENS OF TB, INCLUDING THE INCREASING THREAT OF MULTIDRUG-RESISTANT TB. WE MOBILIZED COMMUNITIES TO IDENTIFY AND REPORT SYMPTOMS, ENCOURAGED FAMILIES AND INDIVIDUALS TO ACCESS SERVICES, AND INCREASED SERVICES FOR MARGINALIZED POPULATIONS, INCLUDING PRISONERS AND PEOPLE WHO INJECT DRUGS. WE ALSO CONTINUED EFFORTS TO INTEGRATE TB CARE WITH OTHER SERVICES AND PARTNERED WITH TANZANIAN LABORATORIES TO INCREASE TB SURVEILLANCE AND INTRODUCE HIGHER-QUALITY, EASIER-TO-USE TESTS.A KEY COMPONENT OF OUR WORK IN TANZANIA IN 2015 WAS THE INTRODUCTION AND USE OF APPROPRIATE AND SUSTAINABLE DIGITAL HEALTH SOLUTIONS. TOGETHER WITH NATIONAL LEADERS, WE DEVELOPED A SCALABLE APPROACH TO EVIDENCE-BASED DECISION- MAKING TO IMPROVE INFORMATION SYSTEMS AND DATA MANAGEMENT POLICIES. WE ALSO GAVE HEALTH WORKERS NEW TOOLS TO IMPROVE THEIR DAY-TO-DAY PRACTICE. FOR INSTANCE, WE SUPPORTED A NATIONAL EFFORT (ONE OF THE FIRST OF ITS KIND WORLDWIDE) TO USE BAR CODES TO TRACK VACCINES AS THEY MOVE FROM MANUFACTURER TO CLINIC TO USE. WE ALSO SUPPORTED A PILOT PROGRAM TO USE BAR CODES TO HELP IDENTIFY CHILDREN WHO VISIT HEALTH FACILITIES AND TRACK THE VACCINES THEY HAVE ALREADY HAD OR STILL NEED.IN ADDITION, OUR GLOBAL ADVOCATES WORKED WITH TANZANIAN ADVOCATES TO STRENGTHEN NATIONAL AND LOCAL POLICIES THAT SUPPORT THE HEALTH OF WOMEN AND CHILDREN. THIS INCLUDED GATHERING EVIDENCE AND CREATING SPECIFIC RECOMMENDATIONS (SUCH AS INCREASED USE OF PROVEN DRUGS AND APPROACHES) TO ENCOURAGE LEADERS TO PRIORITIZE AND SUPPORT BETTER PREVENTION AND TREATMENT OF DIARRHEAL DISEASE AND PNEUMONIA, THE LEADING CAUSES OF DEATH AMONG CHILDREN IN TANZANIA. IN KENYA, OUR WIDE-REACHING PROJECTS AND PARTNERSHIPS SUPPORT WOMEN, CHILDREN, AND COMMUNITIES TO IMPROVE THEIR HEALTH AND REALIZE THEIR FULL POTENTIAL. IN 2015, AS THE LEADER OF THE AIDS, POPULATION, AND HEALTH INTEGRATED ASSISTANCE (APHIAPLUS) WESTERN PROJECT, WE WORKED WITH MORE THAN 800 PUBLIC AND PRIVATE HEALTH CARE FACILITIES, LOCAL ORGANIZATIONS, COMMUNITIES, GOVERNMENT AGENCIES, HEALTH WORKERS, AND VOLUNTEERS TO STRENGTHEN SERVICES FOR HIV AND TB; MALARIA; MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION; REPRODUCTIVE HEALTH; AND MORE. WE IMPROVED HIV TESTING, TREATMENT, AND CARE FOR MORE THAN 90,000 PEOPLE LIVING WITH HIV TO ENSURE THEY HAVE ACCESS TO ONGOING TREATMENT AND CARE. WE CONTINUED OUR WORK TO ROOT OUT THE GENDER-BASED VIOLENCE THAT INCREASES VULNERABILITY TO HIV AMONG WOMEN AND GIRLS. TO COMBAT MALARIA, WE LEVERAGED THE BROAD SCOPE OF OUR APHIAPLUS EFFORTS TO STRENGTHEN DIAGNOSIS AND CARE AND MOBILIZED COMMUNITIES TO SUPPORT MALARIA CONTROL AND ELIMINATION. WE ADVANCED NEW DIAGNOSTIC TOOLS TO DETECT INFECTION AND STRENGTHENED HEALTH WORKERS' CAPACITY TO USE THEM. OUR WIDE-RANGING EFFORTS TO IMPROVE MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION INCLUDED WORK TO PREVENT MOTHER-TO-CHILD TRANSMISSION OF HIV, STRENGTHEN ACCESS TO CARE BEFORE AND AFTER BIRTH, AND SUPPORT SAFE WATER, SANITATION, AND HYGIENE. NEW FUNDING ALLOWED US TO CONTINUE WORKING WITH NATIONAL LEADERS TO LAY THE FOUNDATION FOR A HUMAN MILK BANKING SYSTEM IN KENYA. ONCE ESTABLISHED, THESE MILK BANKS WILL NOT ONLY PROVIDE LIFESAVING BREASTMILK TO BABIES WHO CANNOT NURSE BUT ALSO PROMOTE BREASTFEEDING AS A KEY INTERVENTION TO SAVE LIVES. IN ADDITION, WE ESTABLISHED OUR NEW CENTER FOR HEALTH INNOVATION IN LEARNING, A "VIRTUAL" TEAM THAT BRINGS TOGETHER RESEARCHERS, HEALTH WORKERS, AND OTHER EXPERTS FROM AROUND THE WORLD TO IMPROVE THE QUALITY AND EFFECTIVENESS OF HEALTH SERVICE DELIVERY IN KENYA AND OTHER LOW-RESOURCE SETTINGS WORLDWIDE. OUR GLOBAL ADVOCATES WORKED TO BUILD LOCAL CAPACITY IN ADVOCACY AND POLICY IN KENYA AND TO ADVANCE KEY POLICY PRIORITIES. THESE PRIORITIES INCLUDED NATIONAL GUIDELINES TO TREAT CHILDHOOD PNEUMONIA WITH AMOXICILLIN AND A CHILD HEALTH POLICY AND NATIONAL STRATEGY TO ENSURE THE RIGHT PRODUCTS AND SERVICES REACH CHILDREN WHO NEED THEM. WE ALSO HELPED TO STRENGTHEN LOCAL HEALTH RESEARCH AND DEVELOPMENT CAPACITY TO CREATE HEALTH SOLUTIONS FOR KENYA, THE REGION, AND THE WORLD. IN THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC), PATH APPLIED OUR IN-DEPTH, ON-THE-GROUND EXPERIENCE AND HEALTH EXPERTISE TO ADDRESS HIV, TB, MALARIA, AND NEGLECTED TROPICAL DISEASES AS WELL AS TO IMPROVE REPRODUCTIVE, MATERNAL, NEWBORN, AND CHILD HEALTH. OUR WORK INCLUDED ADVOCATING AT THE NATIONAL LEVEL TO STRENGTHEN FUNDING FOR ESSENTIAL HEALTH INTERVENTIONS, SUCH AS IMMUNIZATION; PROVIDING TARGETED TECHNICAL ASSISTANCE; AND HELPING LOCAL GROUPS IMPLEMENT INNOVATIVE, LOW-COST TECHNOLOGIES AND EVIDENCE-BASED BEST PRACTICES. OUR WORK UNDER THE PROVIC AND PROVICPLUS PROJECTS HELPED TO EMPOWER COMMUNITIES AND ENHANCE CARE FOR THOSE WITH HIV/AIDS, CONTRIBUTING TOWARD ACHIEVEMENT OF THE JOINT UNITED NATIONS PROGRAM ON HIV/AIDS 90-90-90 TARGETS (90 PERCENT OF PEOPLE LIVING WITH HIV KNOW THEIR STATUS, 90 PERCENT OF THOSE WITH HIV RECEIVE ANTIRETROVIRAL THERAPY, AND 90 PERCENT OF THOSE WHO RECEIVE THERAPY HAVE VIRAL SUPPRESSION WITH SUSTAINED TREATMENT). WE IMPLEMENTED KEY INTERVENTIONS SUCH AS MOBILE "MOONLIGHT" HIV COUNSELING AND TESTING IN TARGETED URBAN LOCATIONS, USE OF "MENTOR MOTHERS" TO SUPPORT HIV-POSITIVE PREGNANT WOMEN, AND PROVISION OF A COMPLETE PACKAGE OF HIV SERVICES AT HEALTH FACILITIES, INCLUDING SERVICES TO PREVENT MOTHER-TO-CHILD TRANSMISSION (PMTCT) AND TO PROVIDE EARLY INFANT DIAGNOSIS, CARE, AND TREATMENT. BY THE END OF 2015, PROVIC AND PROVICPLUS HAD PROVIDED HIV COUNSELING AND TESTING TO MORE THAN 660,000 PEOPLE, REACHED MORE THAN 190,000 PREGNANT WOMEN WITH PMTCT COUNSELING AND TESTING, PROVIDED MORE THAN 13,300 ORPHANS AND VULNERABLE CHILDREN AND PEOPLE LIVING WITH HIV WITH CLINICAL SERVICES, AND TRAINED MORE THAN 8,600 HEALTH WORKERS.PATH'S WORK TO STRENGTHEN ADVOCACY AND POLICY TO IMPROVE HEALTH IN THE DRC LED TO SEVERAL SUCCESSES. FOR EXAMPLE, OUR ADVOCACY EFFORTS CONTRIBUTED TO A DECISION BY THE GOVERNMENT OF THE DRC TO PAY MORE THAN US$2 MILLION TOWARD THE COST OF VACCINES PURCHASED BY GAVI, THE VACCINE ALLIANCE, ALLOWING THE DRC TO MEET A COMMITMENT FOR COFUNDING AND THUS MAINTAIN ELIGIBILITY FOR FUTURE GAVI SUPPORT. IN ADDITION, PATH PARTNERED WITH THE GOVERNMENT TO REVISE THE NATIONAL STRATEGY FOR HUMAN AFRICAN TRYPANOSOMIASIS (SLEEPING SICKNESS)-SHIFTING THE FOCUS FROM DISEASE CONTROL TOWARD ELIMINATION. THE NEW STRATEGY HAS THE POTENTIAL TO DRAMATICALLY ACCELERATE THE DRC'S PROGRESS TOWARD STAMPING OUT THIS DISEASE.	Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

Field	Value	IRS element (for citing)
Expense	$10,245,424	ExpenseAmt
Grant	$3,688,865	GrantAmt
Revenue	$20,000	RevenueAmt
Desc	OTHER PROGRAM SERVICES:ADVOCACY AND PUBLIC POLICY:PATH'S ADVOCACY AND PUBLIC POLICY TEAM WORKS IN THE UNITED STATES, WITH MULTILATERAL HEALTH LEADERS ENGAGED IN GLOBAL POLICY AND PLANNING, AND WITH COUNTRIES AND COMMUNITIES AROUND THE WORLD. WE HELP POLICYMAKERS UNDERSTAND ISSUES AND MOTIVATE THEM TO COMMIT FUNDING, CRAFT POLICIES, AND SPONSOR INITIATIVES TO STRENGTHEN GLOBAL HEALTH EFFORTS. IN 2015, PATH LED ADVOCACY EFFORTS TO ENSURE SUPPORT AMONG POLICYMAKERS IN THE UNITED STATES AND EUROPE FOR RESEARCH AND DEVELOPMENT, MATERNAL AND CHILD HEALTH, AND IMMUNIZATION. WORKING IN PARTNERSHIP WITH KEY COUNTRIES IN AFRICA, WE HELPED ADVANCE POLICIES TO IMPROVE THE HEALTH OF WOMEN AND CHILDREN. FOR EXAMPLE, IN ZAMBIA, THE GOVERNMENT ANNOUNCED THAT IT WOULD ALLOW TRAINED COMMUNITY HEALTH WORKERS TO ADMINISTER INJECTABLE CONTRACEPTIVES TO WOMEN, WHICH IS ESSENTIAL FOR EXPANDING ACCESS TO HARD-TO-REACH POPULATIONS. IN MALAWI, THE GOVERNMENT UPDATED ITS ESSENTIAL MEDICINES LIST TO INCLUDE THREE NEW MATERNAL AND NEWBORN HEALTH SUPPLIES, WHICH HAD PREVIOUSLY BEEN UNAVAILABLE TO MANY WOMEN AND CHILDREN.MARKET DYNAMICS:DURING 2015, PATH ESTABLISHED A MARKET DYNAMICS DEPARTMENT. OUR WORK ON MARKET DYNAMICS ENCOMPASSES EFFORTS TO CHARACTERIZE MARKETS, ASSESS SHORTCOMINGS, AND DESIGN MARKET-BASED INTERVENTIONS TO IMPROVE HEALTH OUTCOMES. THIS WORK COMPLEMENTS PATH'S OTHER EFFORTS, SUCH AS PRODUCT DEVELOPMENT; BUILDS UPON OUR EXISTING STRENGTH IN COMMERCIALIZATION; ALIGNS EXPERTISE ACROSS TEAMS; AND EXPANDS OUR CAPACITY TO ADDRESS MARKET-BASED ISSUES. IN 2015, OUR WORK FOCUSED ON ASSESSING MARKETS AND IMPROVING MARKET FUNCTIONING FOR MALARIA DRUGS AND DRUG INTERMEDIATES, MALARIA DIAGNOSTICS, OXYGEN THERAPY DEVICES, AND DEVICES FOR TREATMENT OF PRECANCEROUS CERVICAL LESIONS.SPECIAL INITIATIVES:PATH IS ENGAGED IN A VARIETY OF PROJECTS THAT GALVANIZE OUR EXPERTISE AND RESOURCES AND THAT OF OUR GLOBAL PARTNERS TO SAVE MORE LIVES, MORE QUICKLY. BY ALIGNING DIVERSE EFFORTS, THESE SPECIAL INITIATIVES INCREASE OUR IMPACT, BRINGING US CLOSER TO A WORLD WHERE HEALTH IS WITHIN REACH FOR EVERYONE, NO MATTER WHERE THEY LIVE.OUR NEW CENTER FOR MALARIA CONTROL AND ELIMINATION, FOR EXAMPLE, STRENGTHENS OUR WORK TO COMBAT MALARIA, INCLUDING EFFORTS IN MORE THAN 22 COUNTRIES. THE CENTER COMBINES PATH'S CUTTING?EDGE RESEARCH AND DEVELOPMENT OF MALARIA DRUGS, DIAGNOSTICS, AND VACCINES WITH THE DEVELOPMENT AND DEPLOYMENT OF SYSTEM AND SERVICE INNOVATIONS AND ENHANCED USE OF DATA TO SCALE UP CRITICALLY IMPORTANT MALARIA PROGRAMS. OUR GOAL IS TO HELP OUR COUNTRY PARTNERS ACCELERATE MOMENTUM TOWARD ACHIEVING THE AUDACIOUS GOAL OF A WORLD WITHOUT MALARIA.IN 2015, THE CENTER IDENTIFIED OPPORTUNITIES TO UNLOCK NEW RESOURCES FOR MALARIA ELIMINATION BY DRAWING ON OUR EXPERTISE ACROSS PROJECTS. IN ADDITION, WE BEGAN DEVELOPING NEW STRATEGIES AND TOOLS TO DETECT AND TREAT MALARIA CAUSED BY THE SPECIES PLASMODIUM VIVAX. ALTHOUGH GLOBAL EMPHASIS TO DATE HAS BEEN ON FIGHTING MALARIA CAUSED BY PLASMODIUM FALCIPARUM (THE MOST LETHAL FORM), MALARIA CAUSED BY P. VIVAX CONTRIBUTES TO CHRONIC ILLNESS, LOST WAGES, AND A LOWER QUALITY OF LIFE THROUGHOUT SOUTH AND SOUTHEAST ASIA, LATIN AMERICA, AND THE HORN OF AFRICA. PATH WORKED IN 2015 TO DEVELOP A COMPREHENSIVE FRAMEWORK OF TOOLS AND APPROACHES TO DETECT, TREAT, AND ELIMINATE P. VIVAX MALARIA-AND TO DEVELOP THE PARTNERSHIPS NECESSARY TO BRING THIS WORK TO SCALE.IN 2015, PATH LAUNCHED THE GLOBAL HEALTH SECURITY PARTNERSHIP AS PART OF A LARGER US GOVERNMENT COMMITMENT TO EMPOWER LOW-RESOURCE COUNTRIES TO ANTICIPATE, PREVENT, AND RESPOND TO OUTBREAKS OF INFECTIOUS DISEASE. IN OUR INTERCONNECTED WORLD, THERE IS AN INCREASED RISK OF THE EMERGENCE AND SPREAD OF INFECTIOUS DISEASES, AS EVIDENCED BY THE 2016 ZIKA VIRUS OUTBREAK AND THE 2014 EBOLA OUTBREAK.WITH THE SUPPORT OF THE US CENTERS FOR DISEASE CONTROL AND PREVENTION, PATH WORKED IN 2015 WITH NATIONAL LEADERS IN SENEGAL, TANZANIA, AND VIETNAM TO STRENGTHEN THEIR PUBLIC HEALTH SYSTEMS AND BUILD THEIR CAPACITY TO PREVENT, DETECT, AND RESPOND TO PUBLIC HEALTH EMERGENCIES.AT THE SAME TIME, OUR GLOBAL HEALTH INNOVATION HUBS IN INDIA AND SOUTH AFRICA CONTINUED TO SUPPORT THE "ECOSYSTEM" OF INVESTMENT, MENTORSHIP, AND TECHNICAL ASSISTANCE THAT BRINGS GOOD IDEAS TO WIDESPREAD USE. THE HUBS CONNECT LOCAL GOVERNMENTS, EDUCATIONAL INSTITUTIONS, AND PUBLIC- AND PRIVATE-SECTOR STAKEHOLDERS TO BOLSTER LOCAL INNOVATORS WHEREVER THEY NEED HELP-FROM PRODUCT DESIGN AND CLINICAL VALIDATION THROUGH REGULATORY APPROVAL, COMMERCIALIZATION, AND MARKET DEVELOPMENT. THROUGH THE HUBS, PATH IS INCREASING THE RATE AT WHICH HEALTH-RELATED TOOLS ARE DEVELOPED, INTRODUCED, AND SCALED UP. IN 2015, WE ADVANCED SEVERAL TECHNOLOGIES THROUGH THE HUBS AND EXPLORED WAYS TO EXPAND THE MODEL TO ADDITIONAL COUNTRIES.PATH ALSO ESTABLISHED A SPECIAL INITIATIVE ON NUTRITION INNOVATION BECAUSE UNDERNUTRITION CONTRIBUTES TO AN ESTIMATED 3 MILLION CHILD DEATHS EACH YEAR AND CURRENT NUTRITION INTERVENTIONS HAVE PROVEN INADEQUATE. OUR SPECIAL INITIATIVE BUILDS ON OUR EXISTING NUTRITION EFFORTS AND IDENTIFIES NEW OPPORTUNITIES AND PARTNERSHIPS IN NUTRITION AND RELATED AREAS, SUCH AGRICULTURE; WATER, SANITATION, AND HYGIENE; AND CLIMATE CHANGE TO SUSTAINABLY AND EFFECTIVELY ADDRES MALNUTRITION NOW AND INTO THE FUTURE.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$10,245,424	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$3,688,865	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$20,000	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$213,391,089	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Temp Or Permanent Endowments	Yes (1)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	0	ReportOtherLiabilitiesInd
Include FIN48 Footnote	0	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	0	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	0	ProfessionalFundraisingInd
Fundraising Activities	0	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	Yes (1)	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	0	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	Yes (1)	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	0	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (1)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (1)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
Info In Schedule O Part V	Yes (X)	InfoInScheduleOPartVInd
IRP Document	247	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	757	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	Yes (1)	ForeignFinancialAccountInd
Foreign Country	BE	ForeignCountryCd
Foreign Country	CB	ForeignCountryCd
Foreign Country	CH	ForeignCountryCd
Foreign Country	CG	ForeignCountryCd
Foreign Country	ET	ForeignCountryCd
Foreign Country	FR	ForeignCountryCd
Foreign Country	GH	ForeignCountryCd
Foreign Country	IN	ForeignCountryCd
Foreign Country	KE	ForeignCountryCd
Foreign Country	MI	ForeignCountryCd
Foreign Country	MZ	ForeignCountryCd
Foreign Country	OC	ForeignCountryCd
Foreign Country	PE	ForeignCountryCd
Foreign Country	SG	ForeignCountryCd
Foreign Country	SF	ForeignCountryCd
Foreign Country	SZ	ForeignCountryCd
Foreign Country	TZ	ForeignCountryCd
Foreign Country	TH	ForeignCountryCd
Foreign Country	UG	ForeignCountryCd
Foreign Country	UK	ForeignCountryCd
Foreign Country	UP	ForeignCountryCd
Foreign Country	VM	ForeignCountryCd
Foreign Country	ZA	ForeignCountryCd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	0	QuidProQuoContributionsInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	12	GoverningBodyVotingMembersCnt
Independent Voting Member	12	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	OLIVIA POLIUS CHIEF FINANCIAL OFFICER	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Phone	2062853500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2201 WESTLAKE AVE SUITE 200	AddressLine1Txt
City	SEATTLE	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98121	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (27 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
DEAN ALLEN
CHAIR	2.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
GEORGE GOTSADZE
VICE CHAIR	2.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
FELIX OLALE
SECRETARY	2.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
DAVID KING
TREASURER	2.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
JO ADDY
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
PHYLLIS CAMPBELL
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
ALEX CHIKA EZEH
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
RAJENDRA VATTIKUTI
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
KEVIN REILLY
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
TSITSI MASIYIWA
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
IREENA VITTAL
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
YEHONG ZHANG
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
STEPHEN B DAVIS
PRESIDENT AND CEO	38.00	2.00		Yes (X)	$607,729	$0	$59,038
MICHAEL B KOLLINS
CHIEF OPERATING OFFICER	40.00	0.00		Yes (X)	$277,018	$0	$47,051
OLIVIA D POLIUS
CHIEF FINANCIAL OFFICER	38.00	2.00		Yes (X)	$264,997	$0	$46,727
DAVID C KASLOW
VP - PRODUCT DEVELOPMENT	38.00	2.00			$316,540	$0	$58,018	Yes (X)
AMIE E BATSON
CHIEF STRATEGY OFFICER	39.00	1.00			$283,722	$0	$30,937	Yes (X)
DANIEL LASTER
GENERAL COUNSEL	38.00	2.00			$268,812	$0	$39,328	Yes (X)
KATHY CAHILL
VP - INTERNATIONAL DEVELOPMENT	40.00	0.00			$246,743	$0	$17,393	Yes (X)
DAVID W FLEMING
VP - PUBLIC HEALTH	40.00	0.00			$235,724	$0	$35,118	Yes (X)
KATHRYN A O'DRISCOLL
CHIEF HUMAN RESOURCES OFFICER	40.00	0.00			$228,870	$0	$42,452	Yes (X)
MARK D MURRAY
VP - GLOBAL ENGAGEMENT	40.00	0.00			$159,809	$0	$19,900	Yes (X)
JOHN SKIBIAK
ASSOCIATE DIRECTOR	40.00	0.00			$385,415	$0	$97,321		Yes (X)
JAMES B MCKENNA
ASSOCIATE DIRECTOR	40.00	0.00			$325,662	$0	$71,016		Yes (X)
TRAD M HATTON
CHIEF OF PARTY	40.00	0.00			$285,519	$0	$37,425		Yes (X)
RIKKA E TRANGSRUD
COUNTRY PROGRAM LEADER	40.00	0.00			$282,119	$0	$33,289		Yes (X)
ASHLEY J BIRKETT
GLOBAL PROGRAM LEADER	40.00	0.00			$279,786	$0	$50,480		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$4,448,465	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$685,493	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	267	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	0	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
AEROTEK INC
7301 PARKWAY DRIVE S	HANOVER	MD	21076	STAFFING SERVICES	$1,447,519
WIDENET CONSULTING GROUP LLC
11400 SE 6TH ST 130	BELLEVUE	WA	98004	CONSULTING	$871,041
VOLT MANAGEMENT CORP
2401 N GLASSELL ST	ORANGE	CA	92865	STAFFING SERVICES	$316,898
CLARK NUBER & CO PS
10900 NE 4TH STREET 1700	BELLEVUE	WA	98004	ACCOUNTING SERVICES	$258,344
NORTHERN TRUST
50 S LASALLE ST	CHICAGO	IL	60675	ASSET MANAGEMENT	$251,009

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	28	CntrctRcvdGreaterThan100KCnt
Related Organizations	$20,019,449	RelatedOrganizationsAmt
Government Grants	$112,658,199	GovernmentGrantsAmt
All Other Contributions	$110,822,144	AllOtherContributionsAmt
Noncash Contributions	$7,414,673	NoncashContributionsAmt
Total Contributions	$243,499,792	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
HONORARIUM	900099	$23,740	$23,740
SALES	900099	$1,056	$1,056

Field	Value	IRS element (for citing)
Total Program Service Revenue	$24,796	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,471,233	TotalRevenueColumnAmt
Exclusion	$1,471,233	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$33,714,492	SecuritiesAmt
Other	$33,000	OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$33,299,270	SecuritiesAmt
Other	$10,819	OtherAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$415,222	SecuritiesAmt
Other	$22,181	OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$437,403	TotalRevenueColumnAmt
Exclusion	$437,403	ExclusionAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$130,609	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$168,307	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$37,698	TotalRevenueColumnAmt
Related Or Exempt Func Income	-$37,698	RelatedOrExemptFuncIncomeAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	ExclusionExclusionAmt
OTHER	900099	$1,856,704	$1,856,704
GAIN-FOREIGN EXCH.	900099	$461,667	$461,667
REIMBURSEMENTS	900099	$233,131	$233,131

Field	Value	IRS element (for citing)
Other Revenue Total	$2,551,502	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$247,947,028	TotalRevenueColumnAmt
Related Or Exempt Func Income	-$12,902	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$4,460,138	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$29,384,116	TotalAmt
Program Services	$29,384,116	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$59,013	TotalAmt
Program Services	$59,013	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$31,854,326	TotalAmt
Program Services	$31,854,326	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$3,285,925	TotalAmt
Program Services	$849,768	ProgramServicesAmt
Management And General	$2,371,322	ManagementAndGeneralAmt
Fundraising	$64,835	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$82,352,339	TotalAmt
Program Services	$50,486,887	ProgramServicesAmt
Management And General	$30,573,539	ManagementAndGeneralAmt
Fundraising	$1,291,913	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$7,731,338	TotalAmt
Management And General	$7,731,338	ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$10,954,519	TotalAmt
Program Services	$669,203	ProgramServicesAmt
Management And General	$10,285,316	ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$6,042,548	TotalAmt
Program Services	$366,124	ProgramServicesAmt
Management And General	$5,676,424	ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$379,660	TotalAmt
Program Services	$43,032	ProgramServicesAmt
Management And General	$336,628	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$460,442	TotalAmt
Program Services	$38,838	ProgramServicesAmt
Management And General	$421,604	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$56,008	TotalAmt
Program Services	$24,000	ProgramServicesAmt
Management And General	$32,008	ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$190,639	TotalAmt
Management And General	$190,639	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$9,825,034	TotalAmt
Program Services	$6,817,283	ProgramServicesAmt
Management And General	$2,901,610	ManagementAndGeneralAmt
Fundraising	$106,141	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$268,310	TotalAmt
Program Services	$120,515	ProgramServicesAmt
Management And General	$88,351	ManagementAndGeneralAmt
Fundraising	$59,444	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$4,912,752	TotalAmt
Program Services	$3,726,973	ProgramServicesAmt
Management And General	$1,113,660	ManagementAndGeneralAmt
Fundraising	$72,119	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$1,118,797	TotalAmt
Program Services	$521,291	ProgramServicesAmt
Management And General	$556,370	ManagementAndGeneralAmt
Fundraising	$41,136	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$38,100	TotalAmt
Program Services	$38,100	ProgramServicesAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$10,296,364	TotalAmt
Program Services	$377,585	ProgramServicesAmt
Management And General	$9,918,779	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$18,378,870	TotalAmt
Program Services	$16,337,778	ProgramServicesAmt
Management And General	$1,977,943	ManagementAndGeneralAmt
Fundraising	$63,149	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$6,481,513	TotalAmt
Program Services	$5,861,428	ProgramServicesAmt
Management And General	$363,462	ManagementAndGeneralAmt
Fundraising	$256,623	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$57,803	TotalAmt
Management And General	$57,803	ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$2,316,090	TotalAmt
Program Services	$44,795	ProgramServicesAmt
Management And General	$2,271,295	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$400,377	TotalAmt
Program Services	$44,216	ProgramServicesAmt
Management And General	$356,161	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
SUBCONTRACTS	$21,138,346	$19,989,975	$563,642	$584,729
EQUIP RENT & MAINT	$5,687,802	$3,831,961	$1,826,972	$28,869
FACILITIES ALLOC	$0	$10,352,823	-$10,692,678	$339,855
LEAVE & BENS ALLOC	$0	$25,054,283	-$25,725,231	$670,948

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$9,909,901	TotalAmt
Program Services	$6,496,776	ProgramServicesAmt
Management And General	$3,417,819	ManagementAndGeneralAmt
Fundraising	-$4,694	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$263,580,932	TotalAmt
Program Services	$213,391,089	ProgramServicesAmt
Management And General	$46,614,776	ManagementAndGeneralAmt
Fundraising	$3,575,067	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$27,155,160	BOYAmt
EOY	$17,233,932	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$85,106,641	BOYAmt
EOY	$70,140,432	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$225,750,342	BOYAmt
EOY	$213,160,918	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$12,072,596	BOYAmt
EOY	$8,998,343	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$2,917,489	BOYAmt
EOY	$8,519,638	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$34,928,052	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$19,722,070	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$16,920,582	BOYAmt
EOY	$15,205,982	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$125,648,641	BOYAmt
EOY	$125,477,380	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$44,795	BOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$495,616,246	BOYAmt
EOY	$458,736,625	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$50,802,396	BOYAmt
EOY	$44,777,022	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$3,404,022	BOYAmt
EOY	$2,467,142	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$54,206,418	BOYAmt
EOY	$47,244,164	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$19,517,592	BOYAmt
EOY	$20,834,939	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$418,505,291	BOYAmt
EOY	$387,267,912	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$3,386,945	BOYAmt
EOY	$3,389,610	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$441,409,828	BOYAmt
EOY	$411,492,461	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$495,616,246	BOYAmt
EOY	$458,736,625	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	-$15,633,904	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$1,116,541	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	-$13,166,922	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	Yes (1)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (1)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$240,628,741	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$171,536,869	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$260,656,932	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$286,891,535	CurrentTaxYearMinus1YearAmt
Current Tax Year	$243,499,792	CurrentTaxYearAmt
Total	$1,203,213,869	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$240,628,741	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$171,536,869	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$260,656,932	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$286,891,535	CurrentTaxYearMinus1YearAmt
Current Tax Year	$243,499,792	CurrentTaxYearAmt
Total	$1,203,213,869	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$410,427,009	SubstantialContributorsTotAmt
Public Support Total170	$792,786,860	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$2,797,154	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$2,295,453	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$1,577,831	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$1,370,599	CurrentTaxYearMinus1YearAmt
Current Tax Year	$1,471,233	CurrentTaxYearAmt
Total	$9,512,270	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus1 Year	$38,502	CurrentTaxYearMinus1YearAmt
Total	$38,502	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$502,596	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$730,742	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$2,432,891	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$763,131	CurrentTaxYearMinus1YearAmt
Current Tax Year	$2,551,502	CurrentTaxYearAmt
Total	$6,980,862	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$1,219,745,503	TotalSupportAmt
Gross Receipts Rltd Activities	$288,536	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.65000	PublicSupportCY170Pct
Public Support PY170	0.66290	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$14,461	FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$142,500	FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$156,961	FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$263,423,971	FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$263,580,932	FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$1,000,000	FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$250,000	FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$0	FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$0	FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,000,000	CurrentYearMinus3Amt
Current Year Minus2	$1,000,000	CurrentYearMinus2Amt
Current Year Minus1	$1,000,000	CurrentYearMinus1Amt
Current Year	$1,000,000	CurrentYearAmt
Total	$4,000,000	TotalAmt

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$193,545	CurrentYearMinus3Amt
Current Year Minus2	$106,680	CurrentYearMinus2Amt
Current Year Minus1	$222,686	CurrentYearMinus1Amt
Current Year	$156,961	CurrentYearAmt
Total	$679,872	TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$250,000	CurrentYearMinus3Amt
Current Year Minus2	$250,000	CurrentYearMinus2Amt
Current Year Minus1	$250,000	CurrentYearMinus1Amt
Current Year	$250,000	CurrentYearAmt
Total	$1,000,000	TotalAmt

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus2	$3,098	CurrentYearMinus2Amt
Current Year Minus1	$1,207	CurrentYearMinus1Amt
Current Year	$14,461	CurrentYearAmt
Total	$18,766	TotalAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$9,404,188	BeginningYearBalanceAmt
Contributions	$2,665	ContributionsAmt
Investment Earnings Or Losses	-$58,783	InvestmentEarningsOrLossesAmt
Other Expenditures	$450,846	OtherExpendituresAmt
End Year Balance	$8,897,224	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$9,016,994	BeginningYearBalanceAmt
Contributions	$9,350	ContributionsAmt
Investment Earnings Or Losses	$768,184	InvestmentEarningsOrLossesAmt
Other Expenditures	$390,340	OtherExpendituresAmt
End Year Balance	$9,404,188	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,806,786	BeginningYearBalanceAmt
Contributions	$2,550	ContributionsAmt
Investment Earnings Or Losses	$1,503,301	InvestmentEarningsOrLossesAmt
Other Expenditures	$295,643	OtherExpendituresAmt
End Year Balance	$9,016,994	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$6,868,767	BeginningYearBalanceAmt
Contributions	$5,392	ContributionsAmt
Investment Earnings Or Losses	$932,627	InvestmentEarningsOrLossesAmt
End Year Balance	$7,806,786	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$6,671,532	BeginningYearBalanceAmt
Contributions	$2,700	ContributionsAmt
Investment Earnings Or Losses	$194,535	InvestmentEarningsOrLossesAmt
End Year Balance	$6,868,767	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	0.39000	BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY	0.38000	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.23000	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	0	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	0	EndowmentsHeldRelatedOrgInd

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$20,094,754	OtherCostOrOtherBasisAmt
Depreciation	$9,008,929	DepreciationAmt
Book Value	$11,085,825	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$11,244,084	OtherCostOrOtherBasisAmt
Depreciation	$8,622,298	DepreciationAmt
Book Value	$2,621,786	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$3,589,214	OtherCostOrOtherBasisAmt
Depreciation	$2,090,843	DepreciationAmt
Book Value	$1,498,371	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$15,205,982	TotalBookValueLandBuildingsAmt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART V, LINE 4:	FormAndLineReferenceDesc
Explanation	PATH UTILIZES THE INVESTED INTEREST EARNINGS FROM THE ENDOWMENT AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH, IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY.	ExplanationTxt

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (47 entries)

RegionRegionTxt	OfficesOfficesCnt	EmployeeEmployeeCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Region Total ExpendituresRegionTotalExpendituresAmt	Specific Services ProvidedSpecificServicesProvidedTxt
CENTRAL AMERICA AND THE CARIBBEAN	0	0	MANAGEMENT & GENERAL	-$475
CENTRAL AMERICA AND THE CARIBBEAN	0	0	PROGRAM SERVICES	$39,394	PRODUCT DEVELOPMENT
CENTRAL AMERICA AND THE CARIBBEAN	0	0	PROGRAM SERVICES	$37,983	PUBLIC HEALTH
CENTRAL AMERICA AND THE CARIBBEAN	0	0	GRANTMAKING	$887,791
EAST ASIA AND THE PACIFIC	4	58	MANAGEMENT & GENERAL	$1,621,763
EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	$1,172,665	PRODUCT DEVELOPMENT
EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	$2,348,225	INTERNATIONAL DEVELOPMENT
EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	$560,412	PUBLIC HEALTH
EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	$31,563	OTHER
EAST ASIA AND THE PACIFIC	0	0	GRANTMAKING	$3,095,659
EUROPE	3	25	MANAGEMENT & GENERAL	$2,707,537
EUROPE	0	0	PROGRAM SERVICES	$5,297,548	PRODUCT DEVELOPMENT
EUROPE	0	0	PROGRAM SERVICES	$137,237	INTERNATIONAL DEVELOPMENT
EUROPE	0	0	PROGRAM SERVICES	$3,493,412	PUBLIC HEALTH
EUROPE	0	0	PROGRAM SERVICES	$352,128	OTHER
EUROPE	0	0	GRANTMAKING	$14,928,836
MIDDLE EAST AND NORTH AFRICA	0	0	MANAGEMENT & GENERAL	-$45
MIDDLE EAST AND NORTH AFRICA	0	0	PROGRAM SERVICES	$1,898	PRODUCT DEVELOPMENT
MIDDLE EAST AND NORTH AFRICA	0	0	PROGRAM SERVICES	$7,950	PUBLIC HEALTH
NORTH AMERICA	0	0	MANAGEMENT & GENERAL	$8,833
NORTH AMERICA	0	0	PROGRAM SERVICES	$57,240	PRODUCT DEVELOPMENT
NORTH AMERICA	0	0	PROGRAM SERVICES	$14,015	PUBLIC HEALTH
NORTH AMERICA	0	0	PROGRAM SERVICES	$8,091	OTHER
NORTH AMERICA	0	0	FUNDRAISING	$3,718
NORTH AMERICA	0	0	GRANTMAKING	$150,721
RUSSIA AND NEIGHBORING STATES	1	13	MANAGEMENT & GENERAL	$549,398
RUSSIA AND NEIGHBORING STATES	0	0	PROGRAM SERVICES	$304,029	INTERNATIONAL DEVELOPMENT
RUSSIA AND NEIGHBORING STATES	0	0	PROGRAM SERVICES	$533,725	PUBLIC HEALTH
RUSSIA AND NEIGHBORING STATES	0	0	GRANTMAKING	$268,476
SOUTH AMERICA	1	2	MANAGEMENT & GENERAL	$93,223
SOUTH AMERICA	0	0	PROGRAM SERVICES	$8,096	PRODUCT DEVELOPMENT
SOUTH AMERICA	0	0	PROGRAM SERVICES	$198,212	PUBLIC HEALTH
SOUTH AMERICA	0	0	GRANTMAKING	$234,193
SOUTH ASIA	6	52	MANAGEMENT & GENERAL	$1,667,848
SOUTH ASIA	0	0	PROGRAM SERVICES	$688,950	PRODUCT DEVELOPMENT
SOUTH ASIA	0	0	PROGRAM SERVICES	$1,369,891	INTERNATIONAL DEVELOPMENT
SOUTH ASIA	0	0	PROGRAM SERVICES	$733,334	PUBLIC HEALTH
SOUTH ASIA	0	0	PROGRAM SERVICES	$1,671	OTHER
SOUTH ASIA	0	0	FUNDRAISING	$258
SOUTH ASIA	0	0	GRANTMAKING	$2,279,502
SUB-SAHARAN AFRICA	18	540	MANAGEMENT & GENERAL	$10,272,603
SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	$3,071,457	PRODUCT DEVELOPMENT
SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	$12,134,808	INTERNATIONAL DEVELOPMENT
SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	$19,171,880	PUBLIC HEALTH
SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	$628,481	OTHER
SUB-SAHARAN AFRICA	0	0	FUNDRAISING	$4,107
SUB-SAHARAN AFRICA	0	0	GRANTMAKING	$10,009,148

Field	Value	IRS element (for citing)
Subtotal Offices	4	SubtotalOfficesCnt
Subtotal Employees	58	SubtotalEmployeesCnt
Continutation Total Office	29	ContinutationTotalOfficeCnt
Continutation Total Employee	632	ContinutationTotalEmployeeCnt
Total Office	33	TotalOfficeCnt
Total Employee	690	TotalEmployeeCnt
Subtotal Spent	$6,667,758	SubtotalSpentAmt
Continuation Spent	$94,519,631	ContinuationSpentAmt
Total Spent	$101,187,389	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (300 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
CENTRAL AMERICA AND THE CARIBBEAN	PUBLIC HEALTH	$227,247	CHECK/WIRE
CENTRAL AMERICA AND THE CARIBBEAN	PUBLIC HEALTH	$301,581	CHECK/WIRE
CENTRAL AMERICA AND THE CARIBBEAN	PUBLIC HEALTH	$358,963	CHECK/WIRE
EAST ASIA AND THE PACIFIC	INTERNATIONAL DEVELOPMENT	$56,100	CHECK/WIRE
EAST ASIA AND THE PACIFIC	INTERNATIONAL DEVELOPMENT	$8,812	CHECK/WIRE
EAST ASIA AND THE PACIFIC	INTERNATIONAL DEVELOPMENT	$43,868	CHECK/WIRE
EAST ASIA AND THE PACIFIC	INTERNATIONAL DEVELOPMENT	$522,521	CHECK/WIRE
EAST ASIA AND THE PACIFIC	INTERNATIONAL DEVELOPMENT	$25,381	CHECK/WIRE
EAST ASIA AND THE PACIFIC	INTERNATIONAL DEVELOPMENT	$35,154	CHECK/WIRE
EAST ASIA AND THE PACIFIC	INTERNATIONAL DEVELOPMENT	$23,127	CHECK/WIRE
EAST ASIA AND THE PACIFIC	INTERNATIONAL DEVELOPMENT	$22,289	CHECK/WIRE
EAST ASIA AND THE PACIFIC	INTERNATIONAL DEVELOPMENT	$193,059	CHECK/WIRE
EAST ASIA AND THE PACIFIC	OTHER	$59,803	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$150,000	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$153,642	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$196,179	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$100,339	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$10,230	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$30,000	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$77,479	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$210,541	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$79,192	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PRODUCT DEVELOPMENT	$312,562	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PUBLIC HEALTH	$740,354	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PUBLIC HEALTH	$14,494	CHECK/WIRE
EAST ASIA AND THE PACIFIC	PUBLIC HEALTH	$23,251	CHECK/WIRE
EUROPE	INTERNATIONAL DEVELOPMENT	$20,110	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$16,088	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$37,193	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$271,389	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$127,669	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$210,095	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$173,854	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$110,000	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$7,795	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$123,558	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$141,749	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$206,561	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$126,000	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$56,117	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$88,863	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$21,485	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$67,196	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$37,838	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$2,102,817	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$800,000	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$302,936	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$24,238	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$7,728	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$150,000	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$163,089	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$1,525,146	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$71,861	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$250,649	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$194,610	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$65,503	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$20,946	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$85,000	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$83,062	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$51,934	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$105,872	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$94,459	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$87,420	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$724,350	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$63,755	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$27,667	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$70,786	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$101,412	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$238,543	CHECK/WIRE
NORTH AMERICA	PRODUCT DEVELOPMENT	$105,800	CHECK/WIRE
NORTH AMERICA	PUBLIC HEALTH	$39,921	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$71,342	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$110,501	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	PUBLIC HEALTH	$8,555	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	PUBLIC HEALTH	$8,384	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	PUBLIC HEALTH	$19,115	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	PUBLIC HEALTH	$50,579	CHECK/WIRE
SOUTH AMERICA	PRODUCT DEVELOPMENT	$13,760	CHECK/WIRE
SOUTH AMERICA	PRODUCT DEVELOPMENT	$39,967	CHECK/WIRE
SOUTH AMERICA	PRODUCT DEVELOPMENT	$175,930	CHECK/WIRE
SOUTH ASIA	INTERNATIONAL DEVELOPMENT	$45,275	CHECK/WIRE
SOUTH ASIA	INTERNATIONAL DEVELOPMENT	$538,389	CHECK/WIRE
SOUTH ASIA	INTERNATIONAL DEVELOPMENT	$406,366	CHECK/WIRE
SOUTH ASIA	PRODUCT DEVELOPMENT	$125,887	CHECK/WIRE
SOUTH ASIA	PRODUCT DEVELOPMENT	$9,604	CHECK/WIRE
SOUTH ASIA	PRODUCT DEVELOPMENT	$224,000	CHECK/WIRE
SOUTH ASIA	PRODUCT DEVELOPMENT	$14,263	CHECK/WIRE
SOUTH ASIA	PRODUCT DEVELOPMENT	$30,000	CHECK/WIRE
SOUTH ASIA	PRODUCT DEVELOPMENT	$402,079	CHECK/WIRE
SOUTH ASIA	PRODUCT DEVELOPMENT	$120,000	CHECK/WIRE
SOUTH ASIA	PRODUCT DEVELOPMENT	$5,476	CHECK/WIRE
SOUTH ASIA	PRODUCT DEVELOPMENT	$48,717	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$66,877	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$10,879	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$65,420	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$15,000	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$36,054	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$115,215	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$68,749	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$31,916	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$58,121	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$59,708	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$17,646	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$62,614	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$13,526	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,696	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,233	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$38,644	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,855	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$27,223	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,103	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,934	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$22,788	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,913	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$21,239	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,914	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,023	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,509	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$19,856	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$20,724	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$58,779	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$82,289	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$152,626	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$80,424	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$18,584	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$112,848	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$18,125	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,640	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$47,940	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$20,697	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$21,120	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$23,324	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$24,560	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$78,691	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$44,868	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,941	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$47,295	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$21,932	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$20,086	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$72,097	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,875	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$22,112	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,307	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$35,762	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$20,883	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$13,595	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$18,384	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$60,668	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,621	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$19,470	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$143,321	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$42,013	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$73,936	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,658	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$24,444	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,886	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$19,320	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,010	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$71,352	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,883	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$10,746	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$17,493	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$17,956	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$17,091	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$81,186	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,937	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$13,355	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,361	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$109,684	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$10,893	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$107,057	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$23,076	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,791	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,901	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,550	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$13,413	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$18,505	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$25,052	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$10,815	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$14,757	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$143,046	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$56,553	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$18,173	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$14,922	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$13,783	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$18,970	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,976	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$17,269	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$36,000	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,950	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$76,173	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$50,319	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$54,977	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$20,160	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$10,987	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$48,316	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$71,277	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,577	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$10,650	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$18,429	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$17,579	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$13,301	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,904	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$8,000	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,116	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$39,554	CHECK/WIRE
SUB-SAHARAN AFRICA	OTHER	$7,511	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$24,930	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$197,453	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$251,005	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$28,498	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$26,442	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$1,484,050	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$39,872	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$121,448	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$58,578	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$29,085	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$17,387	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$46,755	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$7,111	CHECK/WIRE
SUB-SAHARAN AFRICA	PRODUCT DEVELOPMENT	$162,331	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$12,363	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$10,923	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$354,281	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$24,222	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$6,090	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$9,960	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$6,375	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$9,375	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$15,007	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,400	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$216,679	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$8,040	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$38,392	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$6,199	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,468	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,250	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$6,964	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,900	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$6,720	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$25,238	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$293,922	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$109,224	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$56,385	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$19,702	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$31,769	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$282,364	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,400	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$37,011	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$14,148	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$36,112	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,398	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$79,235	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$32,843	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$44,896	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$6,785	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$27,233	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$9,957	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$13,042	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$11,175	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$35,510	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$33,324	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$18,795	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,738	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$8,330	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$99,522	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,900	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$30,829	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$102,340	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$12,077	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$6,500	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$18,763	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$9,820	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$40,062	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$314,319	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$44,835	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$18,398	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$43,112	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,400	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$7,628	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$13,585	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$16,601	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$43,317	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$6,440	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$36,387	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$52,473	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$170,414	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$33,830	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$34,455	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$215,404	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$48,810	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$69,327	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$72,198	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$7,797	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$63,549	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$50,603	CHECK/WIRE
EUROPE	INTERNATIONAL DEVELOPMENT	$7,087	CHECK/WIRE
EUROPE	PRODUCT DEVELOPMENT	$2,982,658	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$149,631	CHECK/WIRE
EUROPE	OTHER	$2,532,119	CHECK/WIRE

Field	Value	IRS element (for citing)
Total501c3 Org	255	Total501c3OrgCnt
Total Other Org	45	TotalOtherOrgCnt
Transfer To Foreign Corp	Yes (1)	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	SUBRECIPIENTS MUST SUBMIT PROGRESS REPORTS THAT ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS OR FOLLOW UP ON ANY AREA OF CONCERN. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE PROGRAMMATIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET FUTURE BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (93 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
BROADREACH HEALTHCARE LLC
1655 NORTH FORT MYER DR SUITE 700	ARLINGTON	VA	22209	861052728	N/A	$75,874	INTERNATIONAL DEVELOPMENT
ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION
1140 CONNECTICUT AVENUE NW	WASHINGTON	DC	20036	954191698	501(C)(3)	$4,103,980	INTERNATIONAL DEVELOPMENT
INITIATIVES INC
264 BEACON STREET	BOSTON	MA	02116	042961350	N/A	$346,705	INTERNATIONAL DEVELOPMENT
JHPIEGO
1615 THAMES STREET	BALTIMORE	MD	21231	237424444	501(C)(3)	$1,809,595	INTERNATIONAL DEVELOPMENT
WORLD VISION
300 I ST NE	WASHINGTON DC	DC	20002	951922279	501(C)(3)	$1,709,287	INTERNATIONAL DEVELOPMENT
AMERICAN ACADEMY OF PEDIATRICS
141 NORTHWEST POINT BLVD	ELK GROVE VILLAGE	IL	600071098	362275597	501(C)(3)	$45,509	OTHER
JSI RESEARCH & TRAINING INSTITUTE INC
1616 NORTH FORT MYER DRIVE 11TH	ARLINGTON	VA	22209	042578579	N/A	$13,010	OTHER	FLOOR
SAVE THE CHILDREN ACTION NETWORK
2000 L STREET NW SUITE 500	WASHINGTON	DC	20003	060726487	501(C)(3)	$7,335	OTHER
VISUAL EPIDEMIOLOGY INC
88B HOWE STREET	NEW HAVEN	CT	06511	455049084	N/A	$55,300	OTHER
WORLD VISION INC
34834 WEYERHAEUSER WAY S	FEDERAL WAY	WA	98063	951922279	501(C)(3)	$7,283	OTHER
ACCELOVANCE INC
2276 RESEARCH BOULEVARD SUITE 700	ROCKVILLE	MD	20850	200956757	N/A	$249,738	PRODUCT DEVELOPMENT
ADVANCED BIOSCIENCE LABORATORIES INC
9800 MEDICAL CENTER DRIVE BUILDING	ROCKVILLE	MD	20850	621242262	N/A	$451,195	PRODUCT DEVELOPMENT	D
BECTON DICKINSON
ONE BECTON DRIVE	FRANKLIN LAKES	NJ	07417	220761200	N/A	$212,000	PRODUCT DEVELOPMENT
BOSTON UNIVERSITY
ONE SILBER WAY	BOSTON	MA	02215	042103547	501(C)(3)	$82,793	PRODUCT DEVELOPMENT
CASCADE DESIGNS INC
4000 FIRST AVENUE SOUTH	SEATTLE	WA	98134	910969695	N/A	$215,000	PRODUCT DEVELOPMENT
CATALYTICA INC
4332 FRANCIS AVE N SUITE 5	SEATTLE	WA	98103	262673830	N/A	$46,300	PRODUCT DEVELOPMENT
CDC FOUNDATION
CDC FOUNDATION 55 PARK PLACE NE	ATLANTA	GA	30303	582106707	501(C)(3)	$111,337	PRODUCT DEVELOPMENT	SUITE 400
CONRAD
EASTERN VIRGINIA MEDICAL SCHOOL	ARLINGTON	VA	22209	237053028	501(C)(3)	$573,142	PRODUCT DEVELOPMENT	1911 NORTH FORT MYER DRIVE
FINA BIOSOLUTIONS LLC
9430 KEY WEST AVE SUITE 200	ROCKVILLE	MD	20850	205448275	N/A	$43,049	PRODUCT DEVELOPMENT
FOOD & DRUG ADMINISTRATION
10903 NEW HAMPSHIRE AVENUE	SILVER SPRING	MD	20993	530196965	GOV	$538,584	PRODUCT DEVELOPMENT
FRAUNHOFER USA CENTER FOR MOLECULAR BIOTECHNOLOGY
9 INNOVATION WAY SUITE 200	NEWARK	DE	19711	383203030	501(C)(3)	$521,476	PRODUCT DEVELOPMENT
FRED HUTCHINSON CANCER RESEARCH CENTER
PO BOX 19024	SEATTLE	WA	98109	237156071	501(C)(3)	$85,617	PRODUCT DEVELOPMENT
INTERNATIONAL AIDS VACCINE INITIATIVE
110 WILLIAM ST 27TH FLOOR	NEW YORK	NY	10038	133870223	501(C)(3)	$133,925	PRODUCT DEVELOPMENT
JHU BLOOMBERG SCHOOL OF PUBLIC HEALTH
615 N WOLFE STREET	BALTIMORE	MD	21205	131687001	501(C)(3)	$48,636	PRODUCT DEVELOPMENT
JOHNS HOPKINS UNIVERSITY
OFFICE OF RESEARCH ADMINISTRATION	BALTIMORE	MD	21205	131687001	501(C)(3)	$355,468	PRODUCT DEVELOPMENT	615 N WOLFE STREET W1100
JWM ASSOCIATES LLC
PO BOX 818	OCEAN SHORES	WA	98569	412039407	N/A	$6,642	PRODUCT DEVELOPMENT
KARL WEYRAUCH DBA PYGMY SURVIVAL ALLIANCE
4545 49TH AVE NE	SEATTLE	WA	98105	270438932	501(C)(3)	$9,000	PRODUCT DEVELOPMENT
LOYOLA UNIVERSITY CHICAGO
6339 N SHERIDAN ROAD	CHICAGO	IL	60660	361408475	501(C)(3)	$193,563	PRODUCT DEVELOPMENT
MANN GLOBAL HEALTH LLC
1317 BELMONT DRIVE	COLUMBIA	SC	29205	472218176	N/A	$17,335	PRODUCT DEVELOPMENT
NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
6610 ROCKLEDGE DRIVE MSC 6612	BETHESDA	MD	20892	520858115	GOV	$1,335,647	PRODUCT DEVELOPMENT
PPD DEVELOPMENT LP
8551 RESEARCH WAY SUITE 90	MIDDLETON	WI	53562	561640186	N/A	$90,037	PRODUCT DEVELOPMENT
PUBLIC HEALTH INSTITUTE
555 12TH STREET 10TH FLOOR	OAKLAND	CA	946074046	941646278	501(C)(3)	$445,589	PRODUCT DEVELOPMENT
SAINT LOUIS UNIVERSITY
3700 WEST PINE MALL FUSZ HALL SUITE	ST LOIUS	MO	63108	430654872	501(C)(3)	$15,000	PRODUCT DEVELOPMENT	357
SANARIA INC
9800 MEDICAL CENTER DRIVE SUITE	ROCKVILLE	MD	20850	562354362	N/A	$219,311	PRODUCT DEVELOPMENT	A209
SAVE THE CHILDREN FEDERATION INC
501 KINGS HIGHWAY E SUITE 400	FAIRFIELD	CT	06825	060726487	501(C)(3)	$115,001	PRODUCT DEVELOPMENT
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
307 WESTLAKE AVE N SUITE 500	SEATTLE	WA	98109	910961784	501(C)(3)	$525,000	PRODUCT DEVELOPMENT
SOLAR ELECTRIC LIGHT FUND
1612 K STREET NW SUITE 300	WASHINGTON	DC	20006	521701564	501(C)(3)	$190,000	PRODUCT DEVELOPMENT
TUFTS UNIVERSITY
136 HARRISON AVENUE	BOSTON	MA	02111	042103634	501(C)(3)	$25,000	PRODUCT DEVELOPMENT
UNITED STATES NAVAL MEDICAL RESEARCH CENTER
503 ROBERT GRANT AVE	SILVER SPRING	MD	209107500	470100048	GOV	$348,830	PRODUCT DEVELOPMENT
UNITED STATES PHARMACOPEIAL CONVENTION
12601 TWIN BROOK PARKWAY	ROCKVILLE	MD	208521790	131656692	501(C)(3)	$89,026	PRODUCT DEVELOPMENT
UNITUS LABS
435 S 660 W	OREM	UT	840596078	870621367	501(C)(3)	$150,000	PRODUCT DEVELOPMENT
UNIVERSITY OF ALABAMA AT BIRMINGHAM
701 20TH STREET SOUTH AB 1170	BIRMINGHAM	AL	35294	636005396	501(C)(3)	$100,000	PRODUCT DEVELOPMENT
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
505 PARNASSUS AVENUE	SAN FRANCISCO	CA	94143	946036493	501(C)(3)	$167,996	PRODUCT DEVELOPMENT
UNIVERSITY OF FLORIDA
219 GRINTER HALL PO BOX 115500	GAINESVILLE	FL	326115500	596002052	501(C)(3)	$16,903	PRODUCT DEVELOPMENT
UNIVERSITY OF MARYLAND BALTIMORE
PO BOX 41428	BALTIMORE	MD	212036428	526002033	501(C)(3)	$653,897	PRODUCT DEVELOPMENT
UNIVERSITY OF MIAMI
1320 SOUTH DIXIE HIGHWAY GABLES ONE	CORAL GABLES	FL	33146	590624458	501(C)(3)	$149,332	PRODUCT DEVELOPMENT	TOWER SUITE 650
UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE
85 SOUTH PROSPECT STREET WATERMAN	BURLINGTON	VT	05405	030179440	501(C)(3)	$114,486	PRODUCT DEVELOPMENT	217
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVE NE BOX 359472	SEATTLE	WA	98195	916001537	501(C)(3)	$1,104,688	PRODUCT DEVELOPMENT
WALTER REED ARMY INSTITUTE OF RESEARCH
503 ROBERT GRANT DRIVE	SILVER SPRING	MD	209107500	520664528	GOV	$997,988	PRODUCT DEVELOPMENT
WORLD VISION INC
34834 WEYERHAEUSER WAY S	FEDERAL WAY	WA	98063	951922279	501(C)(3)	$51,750	PRODUCT DEVELOPMENT
YALE UNIVERSITY
PO BOX 1873	NEW HAVEN	CT	065081873	060646973	501(C)(3)	$40,000	PRODUCT DEVELOPMENT
ABT ASSOCIATES
4550 MONTGOMERY AVE SUITE 800 NORTH	BETHESDA	MD	20814	042347643	N/A	$71,793	PUBLIC HEALTH	NORTH
BASIC HEALTH INTERNATIONAL INC
THE MOUNT SINAI MEDICAL CENTER ONE	NEW YORK	NY	100296574	203408717	501(C)(3)	$148,627	PUBLIC HEALTH	GUSTAV L LEVY PLACE PO BOX 1170
BOSTON UNIVERSITY
ONE SILBER WAY	BOSTON	MA	02215	042103547	501(C)(3)	$83,506	PUBLIC HEALTH
BRAC USA
110 WILLIAM STREET 29TH FLOOR	NEW YORK	NY	10038	208456741	501(C)(3)	$116,278	PUBLIC HEALTH
CHILDFUND INTERNATIONAL
2821 EMERYWOOD PARKWAY	RICHMOND	VA	23294	540536100	501(C)(3)	$88,804	PUBLIC HEALTH
CHRISTIAN CONNECTIONS FOR INTERNATIONAL HEALTH
1329 SHEPARD DRIVE SUITE 6	STERLING	VA	20164	541932761	501(C)(3)	$146,227	PUBLIC HEALTH
ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION
1140 CONNECTICUT AVENUE NW	WASHINGTON	DC	20036	954191698	501(C)(3)	$357,721	PUBLIC HEALTH
ENGENDERHEALTH
440 NINTH AVENUE	NEW YORK	NY	10001	131623838	501(C)(3)	$194,182	PUBLIC HEALTH
EVIDENCE ACTION
641 S ST NW 3RD FL WEWORK	WASHINGTON	DC	20001	900874591	501(C)(3)	$126,377	PUBLIC HEALTH
FAMILY CARE INTERNATIONAL INC
45 BROADWAY SUITE 320	NEW YORK	NY	10006	237413005	501(C)(3)	$164,056	PUBLIC HEALTH
FAMILY HEALTH INTERNATIONAL 360
359 BLACKWELL ST SUITE 200	DURHAM	NC	27701	237413005	501(C)(3)	$116,378	PUBLIC HEALTH
FINANCING FOR DEVELOPMENT
1800 MASSACHUSETTS AVENUE SUITE 400	WASHINGTON	DC	20036	680683026	501(C)(3)	$123,118	PUBLIC HEALTH
FRED HUTCHINSON CANCER RESEARCH CENTER
PO BOX 19024	SEATTLE	WA	98109	237156070	501(C)(3)	$9,829	PUBLIC HEALTH
GEORGETOWN UNIVERSITY INSTITUTE FOR REPRODUCTIVE HEALTH
4301 CONNECTICUT AVENUE NW SUITE	WASHINGTON	DC	20008	530196603	501(C)(3)	$155,265	PUBLIC HEALTH	310
GLOBAL HEALTH INSIGHTS LLC
3 PETER COOPER ROAD APT MC	NEW YORK	NY	10010	263809493	N/A	$24,755	PUBLIC HEALTH
GMMB INC
1200 WESTLAKE AVENUE N SUITE 1005	SEATTLE	WA	98109	521305983	N/A	$262,459	PUBLIC HEALTH
HARVARD UNIVERSITY SCHOOL OF PUBLIC HEALTH
INTERNATIONAL HEALTH 677 HUNTINGTON	BOSTON	MA	02115	042103580	501(C)(3)	$245,991	PUBLIC HEALTH	AVENUE
HELEN KELLER INTERNATIONAL
352 PARK AVENUE SOUTH 12TH FLOOR	NEW YORK	NY	10010	135562162	501(C)(3)	$168,443	PUBLIC HEALTH
IBIS REPRODUCTIVE HEALTH
17 DUNSTER STREET SUITE 201	CAMBRIDGE	MA	02138	030382773	501(C)(3)	$31,388	PUBLIC HEALTH
INTERNATIONAL PLANNED PARENTHOOD FEDERATION
125 MAIDEN LANE 9TH FLOOR	NEW YORK	NY	10038	131845455	501(C)(3)	$10,228	PUBLIC HEALTH
INTRAHEALTH INTERNATIONAL
6340 QUADRANGLE DRIVE SUITE 200	CHAPEL HILL	NC	27514	550825466	501(C)(3)	$170,695	PUBLIC HEALTH
JOHN SNOW INC
44 FARNSWORTH STREET	BOSTON	MA	02210	042578580	N/A	$45,696	PUBLIC HEALTH
JSI RESEARCH & TRAINING INSTITUTE INC
1616 NORTH FORT MYER DRIVE 11TH	ARLINGTON	VA	22209	042578580	N/A	$144,230	PUBLIC HEALTH	FLOOR
KYBELE INC
3524 YADKINVILLE ROAD 124	WINSTON SALEM	NC	27106	900759003	501(C)(3)	$512,979	PUBLIC HEALTH
MANAGEMENT SCIENCES FOR HEALTH
200 RIVERS EDGE DRIVE SUITE 320	MEDFORD	MA	02155	042482188	501(C)(3)	$21,775	PUBLIC HEALTH
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREET	BOSTON	MA	02114	041564655	501(C)(3)	$159,999	PUBLIC HEALTH
MEDICAL CARE DEVELOPMENT INC
8401 COLESVILLE ROAD SUITE 425	SILVER SPRING	MD	20910	016022787	501(C)(3)	$3,311,861	PUBLIC HEALTH
PATHFINDER INTERNATIONAL
NINE GALEN STREET SUITE 217	WATERTOWN	MA	02472	530235320	501(C)(3)	$75,322	PUBLIC HEALTH
POPULATION COUNCIL
ONE DAG HAMMARSKJOLD PLAZA 3RD	NEW YORK	NY	10017	131687001	501(C)(3)	$130,569	PUBLIC HEALTH	FLOOR
POPULATION SERVICES INTERNATIONAL
1120 19TH STREET NW SUITE 600	WASHINGTON	DC	20036	560942853	501(C)(3)	$1,269,108	PUBLIC HEALTH
RESULTS FOR DEVELOPMENT INSTITUTE INC
1111 19TH ST NW SUITE 7400	WASHINGTON	DC	20036	208530747	501(C)(3)	$68,100	PUBLIC HEALTH
SAVE THE CHILDREN FEDERATION INC
501 KINGS HIGHWAY E SUITE 400	FAIRFIELD	CT	06825	060726487	501(C)(3)	$294,877	PUBLIC HEALTH
SHIFT LABS INC
1752 NW MARKET ST 211	SEATTLE	WA	98107	454541971	N/A	$10,500	PUBLIC HEALTH
TULANE UNIVERSITY SCHOOL OF PUBLIC HEALTH AND TROPICAL MEDICINE
1440 CANAL ST	NEW ORLEANS	LA	70112	720423889	501(C)(3)	$256,784	PUBLIC HEALTH
UNITED NATIONS FUND FOR POPULATION ACTIVITIES
220 EAST 42ND STREET	NEW YORK	NY	10017		GOV	$121,238	PUBLIC HEALTH
UNITED STATES PHARMACOPEIAL CONVENTION
12601 TWIN BROOK PARKWAY	ROCKVILLE	MD	208521790	131656692	501(C)(3)	$41,043	PUBLIC HEALTH
WIDENET CONSULTING GROUP
2910 1ST AVENUE S SUITE 200	SEATTLE	WA	98134	264198815	N/A	$246,408	PUBLIC HEALTH
PATH DRUG SOLUTIONS
2201 WESTLAKE AVE SUITE 200	SEATTLE	WA	98121	830431851	501(C)(3)	$816,360	OTHER
PATH VACCINE SOLUTIONS
2201 WESTLAKE AVE SUITE 200	SEATTLE	WA	98121	943384500	501(C)(3)	$84,282	OTHER
CENTERS FOR DISEASE CONTROL AND PREVENTION
1600 CLIFTON ROAD	ATLANTA	GA	30333	582106707	GOV	-$50,922	PRODUCT DEVELOPMENT
UW HARBORVIEW MEDICAL CENTER INFECTIOUS DISEASES RESEARCH CLINIC
BOX 359932 HARBORVIEW MEDICAL	SEATTLE	WA	98104	916001537	501(C)(3)	-$5,446	PRODUCT DEVELOPMENT	CENTER 325 9TH AVE
WORLD VISION
300 I ST NE	WASHINGTON DC	DC	20002	951922279	501(C)(3)	-$4,426	PUBLIC HEALTH

Field	Value	IRS element (for citing)
Total501c3 Org	71	Total501c3OrgCnt
Total Other Org	22	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt
PUBLIC HEALTH	1	$15,000
OTHER	2	$44,013

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	SUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE PROGRAMMATIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Idemnification Gross Up Pmts	Yes (X)	IdemnificationGrossUpPmtsInd
Housing Allowance Or Residence	Yes (X)	HousingAllowanceOrResidenceInd
Written Policy Ref T And E Expnss	Yes (1)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (1)	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (1)	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (15 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
STEPHEN B DAVIS
PRESIDENT AND CEO	$458,417	$0	$147,592	$0	$1,720	$0	$31,000	$0	$28,038	$0	$666,767	$0	$0	$0
MICHAEL B KOLLINS
CHIEF OPERATING OFFICER	$275,298	$0	$0	$0	$1,720	$0	$28,326	$0	$18,725	$0	$324,069	$0	$0	$0
OLIVIA D POLIUS
CHIEF FINANCIAL OFFICER	$263,202	$0	$0	$0	$1,795	$0	$31,000	$0	$15,727	$0	$311,724	$0	$0	$0
DAVID C KASLOW
VP - PRODUCT DEVELOPMENT	$314,890	$0	$0	$0	$1,650	$0	$31,000	$0	$27,018	$0	$374,558	$0	$0	$0
AMIE E BATSON
CHIEF STRATEGY OFFICER	$283,722	$0	$0	$0	$0	$0	$30,029	$0	$908	$0	$314,659	$0	$0	$0
DANIEL LASTER
GENERAL COUNSEL	$267,092	$0	$0	$0	$1,720	$0	$31,000	$0	$8,328	$0	$308,140	$0	$0	$0
KATHY CAHILL
VP - INTERNATIONAL DEVELOPMENT	$246,743	$0	$0	$0	$0	$0	$8,111	$0	$9,282	$0	$264,136	$0	$0	$0
DAVID W FLEMING
VP - PUBLIC HEALTH	$235,724	$0	$0	$0	$0	$0	$18,409	$0	$16,709	$0	$270,842	$0	$0	$0
KATHRYN A O'DRISCOLL
CHIEF HUMAN RESOURCES OFFICER	$227,150	$0	$0	$0	$1,720	$0	$25,183	$0	$17,269	$0	$271,322	$0	$0	$0
MARK D MURRAY
VP - GLOBAL ENGAGEMENT	$159,809	$0	$0	$0	$0	$0	$11,076	$0	$8,824	$0	$179,709	$0	$0	$0
JOHN SKIBIAK
ASSOCIATE DIRECTOR	$140,263	$0	$0	$0	$245,152	$0	$17,604	$0	$79,717	$0	$482,736	$0	$0	$0
JAMES B MCKENNA
ASSOCIATE DIRECTOR	$121,278	$0	$0	$0	$204,384	$0	$16,595	$0	$54,421	$0	$396,678	$0	$0	$0
TRAD M HATTON
CHIEF OF PARTY	$115,280	$0	$0	$0	$170,239	$0	$15,091	$0	$22,334	$0	$322,944	$0	$0	$0
RIKKA E TRANGSRUD
COUNTRY PROGRAM LEADER	$180,167	$0	$0	$0	$101,952	$0	$19,820	$0	$13,469	$0	$315,408	$0	$0	$0
ASHLEY J BIRKETT
GLOBAL PROGRAM LEADER	$278,841	$0	$0	$0	$945	$0	$28,360	$0	$22,120	$0	$330,266	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 1A	HOUSING ALLOWANCE & TAX INDEMNIFICATION ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITIONS. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT.
PART I, LINE 7	BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II).

Schedule M IRS990ScheduleM

Cars And Other Vehicles CarsAndOtherVehiclesGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	2	ContributionCnt
Noncash Contributions Rpt F990	$61,125	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FMV	MethodOfDeterminingRevenuesTxt

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	21	ContributionCnt
Noncash Contributions Rpt F990	$182,670	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FMV	MethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp (2 entries)

Non Cash CheckboxNonCashCheckboxInd	DescDesc	ContributionContributionCnt	Noncash Contributions Rpt F990NoncashContributionsRptF990Amt	Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)	SOFTWARE	2	$6,532,998	COST OR SALES PRICE
Yes (X)	SUPPLIES	4	$637,880	COST OR SALES PRICE

Field	Value	IRS element (for citing)
Form8283 Received	0	Form8283ReceivedCnt
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (1)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	0	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, COLUMN (B):	FormAndLineReferenceDesc
Explanation	THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART I, LINE 1	PATH IS A LEADER IN GLOBAL HEALTH INNOVATION. AN INTERNATIONAL NONPROFIT ORGANIZATION, WE SAVE LIVES AND IMPROVE HEALTH, ESPECIALLY AMONG WOMEN AND CHILDREN. WE ACCELERATE INNOVATION ACROSS FIVE PLATFORMS-VACCINES, DRUGS, DIAGNOSTICS, DEVICES, AND SYSTEM AND SERVICE INNOVATIONS-THAT HARNESS OUR ENTREPRENEURIAL INSIGHT, SCIENTIFIC AND PUBLIC HEALTH EXPERTISE, AND PASSION FOR HEALTH EQUITY. BY MOBILIZING PARTNERS AROUND THE WORLD, WE TAKE INNOVATION TO SCALE, WORKING ALONGSIDE COUNTRIES PRIMARILY IN AFRICA AND ASIA TO TACKLE THEIR GREATEST HEALTH NEEDS. TOGETHER, WE DELIVER MEASURABLE RESULTS THAT DISRUPT THE CYCLE OF POOR HEALTH. OUR FUNDERS AND COLLABORATORS SPAN THE PUBLIC, PRIVATE, AND NONPROFIT SECTORS AND ARE PIVOTAL TO OUR SUCCESS. THEIR CONTRIBUTIONS SUPPORT OUR WIDE-REACHING WORK TO ACCELERATE INNOVATION FROM IDEA TO IMPACT. SINCE 2011, PATH AND OUR PARTNERS AND SUPPORTERS HAVE REACHED AN AVERAGE OF 150 MILLION PEOPLE PER YEAR WITH LIFESAVING HEALTH SOLUTIONS.
FORM 990, PART III, LINE 4A	IN ADDITION, PATH HELPED TO LAUNCH THE MOUNTAIN SAFETY RESEARCH SE200 COMMUNITY CHLORINE MAKER IN 2015. THIS PRODUCT IS THE OUTCOME OF A FIVE-YEAR, CROSS-SECTOR PARTNERSHIP TO BRING LOW-COST COMMUNITY WATER SOLUTIONS TO THE GLOBAL MARKET. WIDESPREAD USE COULD HELP TO IMPROVE HEALTH FOR MANY OF THE MORE THAN 600 MILLION PEOPLE WORLDWIDE WHO STILL LACK RELIABLE ACCESS TO CLEAN WATER. PATH'S WORK TO DEVELOP AND INTRODUCE FAST, ACCURATE DIAGNOSTIC TECHNOLOGIES INCLUDES TOOLS TO DETECT AND MONITOR NEGLECTED TROPICAL DISEASES, MALARIA, POLIO, HIV, AND NONCOMMUNICABLE DISEASES, SUCH AS DIABETES. IN A KEY 2015 MILESTONE, WE SUPPORTED COUNTRY UPTAKE OF AN AFFORDABLE, EASY-TO-USE DIAGNOSTIC TEST THAT CAN QUICKLY DETECT PREVIOUS EXPOSURE TO THE PARASITE THAT CAUSES RIVER BLINDNESS (ONCHOCERCIASIS). PATH WORKED WITH PARTNERS TO DEVELOP THE TEST, WHICH WAS LAUNCHED IN 2014. IN 2015, PATH FACILITATED SHIPMENT OF 90,000 TESTS TO SEVEN COUNTRIES AND DEVELOPED RELATED TRAINING MATERIALS. PATH ALSO EVALUATED PROTOTYPES FOR A NEW DUAL-DETECTION TEST FOR BOTH RIVER BLINDNESS AND LYMPHATIC FILARIASIS, A DISEASE THAT CAUSES DISFIGUREMENT AND DISABILITY. WE ALSO EVALUATED PROTOTYPES OF A NEW TEST ONLY FOR LYMPHATIC FILARIASIS. IN ADDITION, PATH ADVANCED DIAGNOSTIC TOOLS FOR OTHER NEGLECTED DISEASES BY DEVELOPING MULTIPLE TARGET PRODUCT PROFILES AND CONDUCTING BIOMARKER, LANDSCAPE, AND MARKET ANALYSES. OUR PIONEERING WORK ON THE USE OF DIAGNOSTICS FOR MALARIA ELIMINATION INCLUDED IMPROVING ACCESS TO AVAILABLE TESTS WHILE DEVELOPING NEW OPTIONS THAT WILL HELP TO IMPROVE TREATMENT. WITH OUR DEVELOPMENT PARTNERS, PATH ADVANCED THREE NEW PROTOTYPES FOR RAPID TESTS FOR G6PD DEFICIENCY, A CONDITION THAT CAN COMPLICATE MALARIA TREATMENT. WE ARE ALSO ADVANCING NEW TESTS THAT CAN DETECT LOW LEVELS OF MALARIA INFECTION THAT MIGHT OTHERWISE BE MISSED. AS PART OF THE GLOBAL EFFORT TO ERADICATE POLIO, PATH ALSO BEGAN A STUDY IN KENYA TO VALIDATE A NEW TEST TO DETECT POLIOVIRUS IN SEWAGE AND CONDUCTED TRAINING IN PAKISTAN TO PREPARE FOR A FIELD VALIDATION STUDY.
FORM 990, PART III, LINE 4B	THROUGH THE MAKING EVERY BABY COUNT INITIATIVE, PATH SUPPORTED GHANA'S CENTRAL GOVERNMENT AND REGIONS TO IMPROVE NEWBORN CARE. WE TRAINED HEALTH CARE WORKERS AND OTHERS ON HOW TO PROVIDE THE BEST NEWBORN CARE AND PROCURE NEEDED COMMODITIES. IN SOUTH AFRICA AND MOZAMBIQUE, THE WINDOW OF OPPORTUNITY PROJECT LED BY PATH SUPPORTED THE PLANNING, PROVISION, AND USE OF CRITICAL MATERNAL AND CHILD HEALTH AND EARLY CHILDHOOD DEVELOPMENT SERVICES IN TARGETED DISTRICTS, WITH STRIKING RESULTS. FOR EXAMPLE, THE PROJECT CONTRIBUTED TO SUBSTANTIAL REDUCTIONS IN MATERNAL MORTALITY, WITH ONE DISTRICT ACHIEVING A 65 PERCENT REDUCTION. PATH ALSO USES INFORMATION AND COMMUNICATIONS TECHNOLOGIES TO IMPROVE HEALTH AND SAVE LIVES AROUND THE WORLD. FROM SYSTEMS THAT IMPROVE DISEASE SURVEILLANCE TO NEW WAYS TO CONNECT PEOPLE TO HEALTH CARE THROUGH THEIR MOBILE PHONES, THESE DIGITAL HEALTH SOLUTIONS (DHS) ARE CRUCIAL TO IMPROVING HEALTH SERVICES WORLDWIDE. IN 2015, OUR GROWING DHS TEAM APPLIED ITS EXPERTISE TO AN INCREASING NUMBER OF PATH PROJECTS. KEY ACCOMPLISHMENTS INCLUDED DEVELOPMENT OF A TOOLKIT ON HOW TO ESTABLISH DATA INDICATORS TO MONITOR PROVIDER PAYMENT SYSTEMS. WE ALSO COLLABORATED WITH THE GOVERNMENT OF TANZANIA TO CREATE AN INVESTMENT ROAD MAP TO IMPROVE NATIONAL HEALTH DATA SYSTEMS AND DATA USE. IN ADDITION, WE APPLIED OUR DIGITAL HEALTH EXPERTISE TO STRENGTHEN THE CAPACITY OF KEY PARTNER COUNTRIES, INCLUDING SENEGAL, TANZANIA, AND VIETNAM, TO DETECT, CONTROL, AND STOP EMERGING INFECTIOUS DISEASES AS PART OF THE GLOBAL HEALTH SECURITY AGENDA. THE BID INITIATIVE, A COLLABORATION BETWEEN PATH AND SUB-SAHARAN AFRICAN COUNTRIES, EMPOWERED COUNTRY GOVERNMENTS TO ENHANCE IMMUNIZATION THROUGH IMPROVED DATA COLLECTION, QUALITY, AND USE. IN 2015, WE LAUNCHED BID INITIATIVE SOLUTIONS IN ZAMBIA AND TANZANIA, INCLUDING NATIONAL ELECTRONIC IMMUNIZATION REGISTRIES AND OTHER INTERVENTIONS THAT PUT THE POWER OF DATA IN THE HANDS OF HEALTH WORKERS. THESE TOOLS AND PRACTICES WILL HELP HEALTH WORKERS TRACK CHILDREN'S IMMUNIZATIONS, FLAG THOSE WHO HAVE MISSED A POTENTIALLY LIFESAVING VACCINE, AND ALERT CAREGIVERS.
FORM 990, PART III, LINE 4C	OTHER WORK IN THE DRC INCLUDED SCALING UP HIGH-QUALITY DIAGNOSTIC AND TREATMENT SERVICES FOR MALARIA AND OTHER FEBRILE ILLNESSES AND INCREASING COVERAGE OF CRITICAL HEALTH INTERVENTIONS FOR MOTHERS AND CHILDREN. THIS INCLUDED EFFORTS TO INCREASE COVERAGE OF FAMILY PLANNING THROUGH COLLABORATION WITH COMMERCIAL FIRMS, NONPROFIT GROUPS, AND GOVERNMENT AGENCIES. IN INDIA, PATH'S WORK HAS RANGED FROM FOSTERING INNOVATION IN HEALTH TECHNOLOGIES, TO INCREASING USE OF MATERNAL AND CHILD HEALTH SERVICES, TO IMPROVING NUTRITION, TO ENCOURAGING HEALTHY BEHAVIORS THROUGH NOVEL TECHNIQUES. ONE AREA OF FOCUS IN 2015 WAS WORKING TO CONTROL THE EPIDEMIC OF TUBERCULOSIS (TB) IN URBAN SLUM POPULATIONS THROUGH SUPPORT FROM FOUNDATIONS AND THE US AGENCY FOR INTERNATIONAL DEVELOPMENT. IN MUMBAI, PATH HAS WORKED WITH LOCAL GOVERNMENT, NONGOVERNMENTAL ORGANIZATIONS, AND PRIVATE-SECTOR PHYSICIANS TO INCREASE ACCESS TO TB DIAGNOSTICS, TREATMENT, AND FOLLOW-UP CARE. THE PROGRAM HAS ENROLLED MORE THAN 4,000 PHYSICIANS IN URBAN AREAS AND PROVIDED CARE AND TREATMENT TO THOUSANDS OF TB PATIENTS. BECAUSE OF THE PROJECT'S SUCCESS IN REACHING POPULATIONS MOST AT RISK FOR TB, THE PROJECT IS BEING REPLICATED IN OTHER CITIES IN INDIA WITH A HIGH BURDEN OF TB.
FORM 990, PART VI, SECTION B, LINE 11	THE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE CHIEF FINANCIAL OFFICER SIGNED THE RETURN.
FORM 990, PART VI, SECTION B, LINE 12C	PATH HAS POLICIES AND PROCEDURES TO ADDRESS CONFLICTS OF INTEREST. PATH MANAGEMENT AND ALL STAFF ABOVE A DESIGNATED LEVEL IN THE ORGANIZATION MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. PATH ALSO HAS A WELL-DEFINED PROCEDURE FOR IDENTIFYING AND REPORTING ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AMONG BOARD MEMBERS. NEW BOARD MEMBERS ARE ASKED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM WITHIN 30 DAYS OF JOINING THE BOARD AND TO COMPLETE A NEW FORM ANNUALLY THEREAFTER. IN ADDITION, MEMBERS ARE REMINDED TO REPORT ANY NEW ISSUES THAT ARISE OUTSIDE OF THE ANNUAL DISCLOSURE PERIOD. THE DISCLOSURE FORMS ARE REVIEWED BY PATH'S GENERAL COUNSEL, AND, IF ANY ACTUAL OR POTENTIAL CONFLICTS ARE IDENTIFIED, GENERAL COUNSEL MAKES A RECOMMENDATION TO THE CHAIR OF THE GOVERNANCE COMMITTEE AND THE CHAIR OF THE BOARD FOR A MANAGEMENT PLAN TO PROPERLY MANAGE ANY CONFLICTS. A FORMAL MANAGEMENT PLAN IS THEN AGREED UPON WITH THE BOARD MEMBER, AND THE ENTIRE BOARD OF DIRECTORS IS INFORMED AT THE NEXT REGULARLY SCHEDULED BOARD MEETING.
FORM 990, PART VI, SECTION B, LINE 15	THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE ANNUALLY REVIEWS SALARY AND BENEFITS FOR EXECUTIVE EMPLOYEE POSITIONS AND PROVIDES GUIDANCE TO THE CEO ON COMPENSATION DECISIONS FOR EXECUTIVE POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT AND CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR AT THE DECEMBER BOARD MEETING. PATH ROUTINELY USES THE SERVICES OF EXTERNAL FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO, VICE PRESIDENTS, AND EXECUTIVE TEAM MEMBERS). THE LAST MAJOR REVIEW WAS COMPLETED IN 2014, WHEN PATH ENGAGED MERCER (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO, VICE PRESIDENTS, AND EXECUTIVE TEAM MEMBERS. MERCER USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE REVIEWED THE MERCER REPORT AND APPROVED THE COMPENSATION PACKAGES FOR THE VICE PRESIDENTS AND EXECUTIVE TEAM. ADDITIONALLY, MERCER REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFIT PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD APPROVED THE COMMITTEE'S RECOMMENDATION FOR THE PRESIDENT/CEO'S TOTAL COMPENSATION PACKAGE.
FORM 990, PART VI, SECTION C, LINE 19	PATH GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST; MOST DOCUMENTS ARE ALSO AVAILABLE ONLINE.
FORM 990, PART XI, LINE 9:	FROM TIME TO TIME, UNSPENT AWARD FUNDS (OR UNUSED OBLIGATIONS) MAY BE RETURNED TO A FUNDER FOR A VARIETY OF REASONS INCLUDING, BUT NOT LIMITED TO, EARLY TERMINATION OF A PROJECT BY A FUNDER, OR A REDUCTION IN FUNDS REQUIRED TO ACCOMPLISH A PROJECT'S SCOPE OF WORK. -13,166,922.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd	Address Line1ForeignAddress/AddressLine1Txt	CityForeignAddress/CityNm	CountryForeignAddress/CountryCd	Legal Domicile Foreign CountryLegalDomicileForeignCountryCd
PATH VACCINE SOLUTIONS
2201 WESTLAKE AVENUE	SEATTLE	WA	98109	830431851	ADVANCE DEVELOPMENT OF VACCINES TO IMPROVE THE HEALTH OF CHILDREN	WA	501(C)(3)	LINE 11A	PATH	Yes (1)
PATH DRUG SOLUTIONS
280 UTAH AVENUE SUITE 250	SAN FRANCISCO	CA	94080	943384500	DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINES	CA	501(C)(3)	LINE 11A	PATH	Yes (1)
FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
					EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH		501(C)(3)		PATH	Yes (1)	207 ROUTE DE FERNEY 1218 LE GRAND-S	GENEVA	SZ	SZ

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	0	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	Yes (1)	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (1)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	0	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	0	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	0	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	0	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	0	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	0	SharingOfFacilitiesInd
Paid Employees Sharing	0	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	0	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	0	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (6 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
PATH VACCINE SOLUTIONS
C	$14,137,772	FMV
PATH VACCINE SOLUTIONS
B	$84,282	FMV
PATH DRUG SOLUTIONS
C	$3,835,141	FMV
PATH DRUG SOLUTIONS
B	$816,360	FMV
FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
C	$2,046,536	FMV
FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
B	$5,671,495	FMV